TW434206B - Methods for the preparation of pyridine derivatives for preparing an antisecretory compound, omeprazole - Google Patents

Methods for the preparation of pyridine derivatives for preparing an antisecretory compound, omeprazole Download PDF

Info

Publication number
TW434206B
TW434206B TW86104131A TW86104131A TW434206B TW 434206 B TW434206 B TW 434206B TW 86104131 A TW86104131 A TW 86104131A TW 86104131 A TW86104131 A TW 86104131A TW 434206 B TW434206 B TW 434206B
Authority
TW
Taiwan
Prior art keywords
patent application
formula
scope
item
compound
Prior art date
Application number
TW86104131A
Other languages
Chinese (zh)
Inventor
Shian-Yan Tzou
Sz-Shian Chen
Sz-Feng Chen
Original Assignee
Dev Center Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dev Center Biotechnology filed Critical Dev Center Biotechnology
Priority to TW86104131A priority Critical patent/TW434206B/en
Application granted granted Critical
Publication of TW434206B publication Critical patent/TW434206B/en

Links

Landscapes

  • Pyridine Compounds (AREA)

Abstract

This invention describes methods for the preparation of pyridine derivatives having the formula, wherein R1 is C1-C4-alkyl, halomethyl, aminomethyl, hydroxymethyl, nitrile or carbonylamino; R2 is C1-C4-alkyl; R3 is hydrogen, halogen or OR31, wherein R31 is C1-C4-alkyl; R4 is C1-C4-alkyl; and R5 is hydrogen, halogen, hydroxy or OP(O)(OR51)2, wherein R51 is methyl or ethyl. The derivatives are for preparing an antisecretory compound, omeprazole.

Description

434206 經濟部中央標準局負工消費合作杜印製434206 Duty Printing Cooperative Work of Central Standards Bureau, Ministry of Economic Affairs

Μ Β7 五、發明説明(1 ) 發明領域 本發明係關於式I吡啶衍生物之新穎製法Μ B7 V. Description of the Invention (1) Field of the Invention The present invention relates to a novel method for preparing a pyridine derivative of formula I

其中, i 烷基,自甲基,胺甲基,羥甲基,腈基或 羰胺基;" R2爲C,- C4 -燒基; R3爲氫,鹵素或OR31,其中R31爲C, - C4 -烷基; R4爲- C4 ·規基;且 R5爲氫’鹵素,羥基及〇P(〇)(〇R51)2 ’其中R”爲甲基 或乙基。 特而3之’其係有關抗胃潰瘍·用藥奥米味吐(〇mepraz〇le ) 吡啶環部分之起始原料及/或合成中間體之衍生物,例如 2,3,5-三甲基吡啶、2,3,5-三甲基-4_曱氧基吡啶及3,5· 一甲基-4-甲氧基ρ比喊-2 -.腈的新穎製備^方法。 -s 發明背景 , 下式之奥采咪吐(Omeprazole ) r OMe (其中Me爲甲基) 45H99.DOC — 4 本紙張尺度適用令國國家標準(CNS ) A4規格(2丨0X297公釐} I I I i HI ^ 訂 I'"I (請先閱讀背面之注意事項再一填寫本頁) 434206 A7 B7 五、發明説明(2 爲-已知的胃酸抑制劑。其藥理機制係作爲質子背浦 (Η + + Κ + )- ΑΤΡ;^的咬制劑。在臨庆η笨田卡由θ ,、 γ 仗瞄床上係用來治燎腸胃道感 染性疾病’例如θ潰瘍及十二指膜、'眘庶 * , 相财殤。奥米咪唑的合成 係由2 -氣甲基·3,5·二甲基-4-甲g並& . 巯基苯幷咪唑經偶合與氧化兩個步驟得到: OMe乂广 XXVs’mAmong them, i alkyl, from methyl, aminomethyl, hydroxymethyl, nitrile or carbonylamino; " R2 is C, -C4-alkyl; R3 is hydrogen, halogen or OR31, where R31 is C, -C4 -alkyl; R4 is -C4-gauge; and R5 is hydrogen'halogen, hydroxyl and OH (OH) (〇R51) 2 'wherein R "is methyl or ethyl. 3' It is related to the anti-gastric ulcer · medicine omeprazole, the starting material of the pyridine ring part and / or derivatives of synthetic intermediates, such as 2,3,5-trimethylpyridine, 2,3,5 -Trimethyl-4-methoxypyridine and 3,5 · monomethyl-4-methoxyρ ratio -2-a novel preparation method of nitrile. -S Background of the invention Omeprazole r OMe (where Me is methyl) 45H99.DOC — 4 This paper applies the national standard (CNS) A4 specification (2 丨 0X297 mm) III i HI ^ Order I '" I (Please First read the notes on the back and fill in this page again) 434206 A7 B7 V. Description of the invention (2 is-a known gastric acid inhibitor. Its pharmacological mechanism is as a proton back pump (Η + + Κ +)-ΑΤΡ; ^ Bite preparation. In Linqing η Bentian card by θ, γ The upper system is used to treat gastrointestinal infectious diseases, such as θ ulcers and duodenal membranes, 'Shenxiong *, Xiangcai'an. The synthesis of omimidazole is composed of 2-aminomethyl · 3,5 · dimethyl -4-methylg &&;; mercaptobenzimidazole is obtained through two steps of coupling and oxidation: OMe 乂 广 XXVs'm

Η Μ = Na, Κ 甲轧基吡哫與5 -甲氧基Η Μ = Na, Κmethinopyridine and 5-methoxy

OMe ---------k-- (請先閱讀背面之注意事項再一填寫本頁) 經濟部中央標準局負工消費合作社印策 (其中Me爲—基) I 歐洲專利EPOOOSHMHTW已揭示2,3,5_三甲基吡啶及其 衍生物是合成奥米咪唑之起始物質2 -氣甲基_3,5_二甲基_ 4 -甲氡基吡啶的重要合成中間體,並揭示其合成方法。 關於2,3,5 -二甲基p比咬之製法已揭示於專利文獻中。例 如,日本專利申請案號JP 59 - 146620係揭示以姑及雷尼錄 (Raney Nickel)混合金屬觸媒催化3,5 -二甲基吡啶與甲醇進 行氣相反應而生成2,3,5 ▲三甲基峨攻。此製程須用到叙昂、 貴的时高壓設備’ ^操作上較具危險性,並且有規化副 >產 物的生成,,' 使產物之分餾程序頗爲繁複。美國專利第 5,061,805號係揭示以過量硫粉將2 -烷基-3,5 -二甲基,比淀之 第二位置的長鏈抗基裂解爲甲基而生成2,3,5 -三甲基tt比咬 。此方法須使用大量且易燃的硫粉,不僅龙險且副產物容 易造成環境污染,且起始物的來源不易獲得。美國專利第 本紙張尺度適用中國國家標寧(CNS } A4規格(210X297公釐) -訂 經濟部中央標準局負工消费合作社印製 A7 B7 五、發明説明(3 ) 4’785,113號係揭tf以3 -胺基-2-甲基.丁烯酸乙酯與單甲基 丙二酸乙酯爲起始物,經縮合反應得到不穩定的中間體, 然後經由驗性分解得到2,4 -二羥基_ 3,5,6 •三甲基吡啶, 接著以难酿氣處理得到2,4 -二氣· 3 , 5,6 -三甲基毗啶,最 後進行觸媒催化氫解反應得到2,3,5 -三曱基吡啶。其中該 縮合反應疋在危險性甚高的鈉砂存在下進行,且氣化反應 需使用一當量之4酷氣’使中和後產生大量廢水^ 但上述製造〃方法仍無法令人十分滿意。例如,3 _胺基-· 2 -甲基-丁烯酸乙酯的製備須在高壓釜中進行,故須具備較 砰貴的設備且’較具危險性;又2,4 -二經基_3 5,6-三曱基 吡啶產率不佳(40 - 50% ),足見縮合反應仍伴隨有其他的副 反應。爲克服以上的困難’吾等乃研究發明出以一種製備 2,3, 5-三甲基u比咬之新穎方法。 關於2-¾甲基- 3,5 -二*ψ基-4-甲氧基峨咬之合成亦已揭· 示於先前技藝。例如,下列二個具代表性的專利係揭示2 · 赵甲基-3 ,5 -二甲基-4-甲氧基p比喊的製備方法,其中歐洲 專利EP 0 005 129 ( 1979 )係%採用2,3,5·三f基吡啶爲起始原、 料’經過氧化、硝化與甲氧化(步驟⑴⑶)得到2,3,5 '三 甲基-4 -甲氧基吡盎氧化物’然後進行醯化反應(步驟⑷) 、水解反應(步驟⑽)得到2 -羥甲基-3,5 -二甲基_ 4 -甲氧基 吡啶。而德國專利DE 3840372 ( 1988 )則採用3,5 -二甲基峨咬 爲起始原料’經過氧化、硝化與氰化(步驟⑸_ (7〇得到2 _ 氰基-3,5-二甲基-4-硝基吡啶,然後再經過甲氧化反應與 氫化反應(步驟⑻-⑼)得到2 -胺甲基-3,5 ·二甲基-4 _甲氧 本紙張尺度適用中國國家標準(CNS ) A4現格(210X297公釐} —--------‘— (請先閱讀背面之注意事項再|填寫本頁) 訂 .^, I · 434206^, A7 B7 五、發明説明(4 基被啶,然後再經重氮化水解反應(步驟⑼)生成2 u超甲基 • 3,5 -二甲基-4 -甲氧基吡啶。經由上述二方法所得到之2 _ 經甲基-3 ,5 -二甲基-4-甲氧基吡啶可再進一步依本身已知 ‘方法行氣化作用得到奥米咪唑之合成起始物質2 -氣甲基_ 3,5-二甲基-4·甲氧基吡啶(步驟(12))。其反應式如下所示:OMe --------- k-- (Please read the precautions on the back and fill in this page again.) The policy of the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (where Me is based) I European patent EPOOOSHMHTW has been It is revealed that 2,3,5-trimethylpyridine and its derivatives are important starting intermediates for the synthesis of omimidazole, 2-aminomethyl_3,5_dimethyl_4-methylpyridine, And revealed its synthesis method. A method for preparing 2,3,5-dimethyl p-biting has been disclosed in the patent literature. For example, Japanese Patent Application No. JP 59-146620 discloses that Raney Nickel mixed metal catalyst catalyzes the reaction of 3,5-dimethylpyridine and methanol to generate 2,3,5 ▲ Trimethyl eutectic. This process requires the use of expensive and expensive high-pressure equipment, which is dangerous in operation, and has a regulated secondary product formation, which makes the product fractionation process quite complicated. U.S. Patent No. 5,061,805 discloses the use of excess sulfur powder to cleave 2-alkyl-3,5-dimethyl, the second-chain long-chain anti-group at the second position into methyl groups to generate 2,3,5- Trimethyl tt than bite. This method requires the use of a large amount of flammable sulfur powder, which is not only risky, but also by-products can easily cause environmental pollution, and the source of the starting material is not easy to obtain. The paper size of the US patent applies to the Chinese national standard (CNS) A4 (210X297 mm)-ordered by the Central Bureau of Standards of the Ministry of Economic Affairs and printed by the Consumer Cooperatives A7 B7 V. Description of the invention (3) 4'785, 113 The tf is based on 3-amino-2-methyl. Ethyl butenoate and ethyl monomethylmalonate as starting materials, and an unstable intermediate is obtained through a condensation reaction, and then 2 is obtained through empirical decomposition. 4 -dihydroxy_ 3,5,6 • trimethylpyridine, followed by treatment with difficult gas to obtain 2,4 -digas · 3,5,6 -trimethylpyridine, and finally catalytic hydrogenolysis reaction 2,3,5-trimethylpyridine was obtained, in which the condensation reaction was carried out in the presence of highly dangerous sodium sand, and the gasification reaction required the use of 4 equivalents of cool gas to generate a large amount of wastewater after neutralization ^ However, the above-mentioned method of manufacturing plutonium is still not very satisfactory. For example, the preparation of 3-amino- · 2-methyl-butenoic acid ethyl ester must be performed in an autoclave, so it must have more expensive equipment and It is dangerous; the yield of 2,4-dienyl_3 5,6-trifluorenylpyridine is not good (40-50%), which shows that the condensation reaction is still accompanied by its In order to overcome the above difficulties, we have researched and invented a novel method for preparing 2,3,5-trimethyl u ratio bite. About 2-¾methyl-3,5-di * ψ group The synthesis of 4-methoxymethoxy bitumen has also been revealed and shown in previous techniques. For example, the following two representative patents disclose the ratio of 2-Methyl-3,5-dimethyl-4-methoxy p The preparation method is as follows, in which the European patent EP 0 005 129 (1979) is based on 2,3,5 · trifylpyridine as the starting material, and the material is obtained through oxidation, nitration and methylation (step ⑴) to obtain 2,3, 5 'trimethyl-4 -methoxypyroxide' and then undergo a halogenation reaction (step ⑷), hydrolysis reaction (step ⑽) to obtain 2-hydroxymethyl-3,5-dimethyl-4 -methyl Oxypyridine, while German patent DE 3840372 (1988) uses 3,5-dimethyl-methyl bite as the starting material, 'oxidation, nitration and cyanation (step ⑸_ (70 to get 2 _ cyano-3,5 -Dimethyl-4-nitropyridine, and then through a methylation reaction and a hydrogenation reaction (steps ⑼-⑼) to obtain 2-aminomethyl-3,5 · dimethyl-4 _methoxy This paper is applicable to China National standard( CNS) A4 is now (210X297 mm) —--------'— (Please read the precautions on the back before filling in this page) Order. ^, I · 434206 ^, A7 B7 V. Description of the invention (4 groups are pyridine, and then undergo diazotization hydrolysis reaction (step ⑼) to produce 2 u supermethyl • 3,5-dimethyl-4 -methoxypyridine. 2_ Methyl-3,5-dimethyl-4-methoxypyridine can be further vaporized in accordance with the method known per se to obtain the starting material for the synthesis of omidimazole, 2-aminomethyl-3,5-di Methyl-4.methoxypyridine (step (12)). The reaction formula is as follows:

請 鬩 背 之 注 och3Please note back och3

2_氱甲基-3,5-二子基 氧基吡啶 項 Λ 填 寫 、 本 ^ 頁 訂 (1) H202/H0Ac (4)Ac20 •(7)(i)(CH3)2S〇4 (10) NaOH/CH3OH, (2) HN〇3 (5)H202/H0Ac (ii)KCN H20(當 RCH2OAc (3) NaOH/CH3OH (6)HN03 (8)CH3ONa/CH3OH 時) ,H20 (9)H2j Ra-Ni (11) (i)NaN02/H0Ac, 〆H20 , 一 (ii)NaOH/H20 ' 、 (當 經濟部中央標準局貝工消費合作社印製 ^ (12) (i)SOCl2⑼中和卜 (其中 Ac 爲 gH3CO ) » 歐洲專利EP 0 005 129 ( 1979 )或德國專利DE 3840372 ( 1988 )所 揭示的方法並無法令人十分滿意,因其都是以吡啶衍生物 作起始物及/或中間體,其中所涉及的硝化及氧化反應都 具有高腐蚀性且硝化吡啶及其氧化物具有潛在的致癌性。 本紙張尺度適用中國國家標準(CNS > Λ4規格(210X297公嫠) A7 B7 五、發明説明(5 爲避免以上缺點’吾等乃研究並發明以不同的途徑來製備 2 -起甲基- 3,5 -一甲基-4-曱氧基p比淀。本發明方法之特徵 在於以線形的起始物爲原料而合成具適當取代基之吨咬衍 生物,而非以環狀吡啶或其衍生物爲起始物。 發明詳細説明 本發明之目的係提供一種製備式la化合物及其衍生物' 方法, ·’2_Methyl-3,5-diasyloxypyridine item Λ Fill in this page (1) H202 / H0Ac (4) Ac20 • (7) (i) (CH3) 2S〇4 (10) NaOH / CH3OH, (2) HN〇3 (5) H202 / H0Ac (ii) KCN H20 (when RCH2OAc (3) NaOH / CH3OH (6) HN03 (8) CH3ONa / CH3OH), H20 (9) H2j Ra-Ni (11) (i) NaN02 / H0Ac, 〆H20, (ii) NaOH / H20 ', (when printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs ^ (12) (i) SOCl2⑼Zhonghebu (where Ac is gH3CO) »The methods disclosed in European Patent EP 0 005 129 (1979) or German Patent DE 3840372 (1988) are not very satisfactory because they all use pyridine derivatives as starting materials and / or intermediates, among which The nitrification and oxidation reactions involved are highly corrosive and the nitropyridine and its oxides are potentially carcinogenic. This paper size is applicable to Chinese national standards (CNS > Λ4 specification (210X297)) A7 B7 V. Description of the invention ( 5 In order to avoid the above shortcomings, we have studied and invented different ways to prepare 2-methyl-3,5-monomethyl-4-fluorenyl p ratio. The method of the present invention is characterized by linear Starting material T synthesized with an appropriately substituted derivative group bite, rather than a cyclic or pyridine derivative as a starting material. The present invention is described in detail object of the invention to provide a process for preparing a compound of the formula la and their derivatives 'method, -'

經濟部中夬標準局負工消費合作社印製 Λ οPrinted by the Offshore Consumers Cooperative of the China Standards Bureau of the Ministry of Economic Affairs Λ ο

45399. DOC 其步驟爲: ⑴以式j_化合物爲起始物與式BCH2 NH2 (其中B爲苯基碑 經取代之苯基)進行脱水反應生成式1保護態的晞胺缓 R2\^C02C2H5 R2\^C〇2C2H5 ΝΗ ι ch2b ⑵將式七保護‘%為胺酯與可供應烷醯陽離子之試劑進’行 烷醯化反應生成式烷醯化晞胺酯衍生物 尺2丫。〇『 r1XnA^R4 2 ;45399. DOC The steps are as follows: ⑴ Dehydration reaction of the compound of formula j_ with the starting material of formula BCH2 NH2 (where B is a phenyl substituted phenyl group) to form a protected amine of formula 1 R2 \ ^ C02C2H5 R2 \ ^ C〇2C2H5 Ν ι ch2b ⑵ The formula VII protected '% is an amine ester and a reagent capable of supplying an alkyl cation to undergo an alkylation reaction to form an alkylated alkyl amine ester derivative. 〇 『r1XnA ^ R4 2;

I ch2b ⑶將式2_燒醯化烯胺酯衍生物經強鹼處理後加熱進行分 -8 -本紙珉尺度適用中國國家標隼(CNS ) A4規格(210X297公釐) 434206^ A7 B7 五、發明説明(6 子内環化生成式比酮衍生物 OH,R4I ch2b (3) The formula 2_burned fluorenated enamine ester derivative is treated with strong alkali and heated to be divided into -8-the paper size is applicable to China National Standard (CNS) A4 specification (210X297 mm) 434206 ^ A7 B7 V. Description of the invention (6 sub-cyclization to form ketone derivative OH, R4

4 將式1衍生物烷基化得到溶解性較佳的.式I化合物, 並將式i化合物經氫解反應得到式I化合物 OR31 .R44 Alkylation of the derivative of formula 1 to obtain a compound of better solubility. The compound of formula I is subjected to a hydrogenolysis reaction to obtain a compound of formula I OR31 .R4

ch2b OR- 31ch2b OR- 31

---------k-- (請先閱讀背面之注意事項j填寫本頁) 經濟部中央橾準局員工消費合作社印33- - -6 (其中R31爲q - C4烷基); ⑸將式化合物與磷醯鹵化物反應,生成式化合物 X ~ .R+ 八 X : ·«=*·» (其中X爲鹵素);及 、、 ⑹式L化洽物可观需要進一步進行氫解去除自素原子得 到式U產物(其中R1、爲Ci_C4烷基且圮及民5爲 氫)--------- k-- (Please read the precautions on the back to fill in this page first.) Employees 'Cooperative Cooperatives' Seal, Central Procurement Bureau, Ministry of Economic Affairs, 33---6 (where R31 is q-C4 alkyl) ; 反应 reacting a compound of formula with a phosphonium halide to form a compound of the formula X ~ .R + Eight X: where «= * ·» (where X is a halogen); Removal from the prime atom gives the product of formula U (where R1 is Ci_C4 alkyl and hydrazone and min 5 are hydrogen)

在上述步驟⑴中,較佳之BO^NK爲;基胺,且該脱水反 9 - 本紙張尺度適用中國國家標準(CNS > Μ規格(210X297公釐〉In the above step ⑴, the preferred BO ^ NK is: amine, and the dehydration is 9-This paper size is applicable to Chinese national standards (CNS > Μ specifications (210X297 mm>

、1T rr A7 B7 五、發明説明(7 ) 應可於苯中及以P _ TSA作爲催化劑下進行。步驟⑵中,較 佳之可供應坡醯陽離子之試劑爲丙醯陽離子,如丙酿氣或 丙酸肝3步驟⑵較佳係於脱酸劑存在下且可視情況於甲苯 或甲基第三丁基醚存在下進行,較佳之脱酸劑實例爲吡啶 、環氧丙燒或三級胺。該烷醯化反應較佳係於4〇 _ 6(TC,最 佳於50°C下進行。步驟⑶中分子内環化反應所使用之強鹼 之較佳實例爲氫化鈉、特丁醇_或胺化鈉,且該分子内環 化較佳係於笨;容劑中進行。步驟⑷之娱^基化反應較佳係於-心(:〇3 /丙網存在下進行,且其中較佳係與二烷基硫酸進 行燒化反應^步驟⑸較佳係於110 - 130°c,最佳於120°C下進 行’且其中較佳之磷酿自化物爲磷酿氯及鱗感漠。及步驟 ⑹之氫解反應較佳係於脱酸劑存在下進行,較佳之脱酸劑 實例爲氨水及乙醇,且其氣解反應較佳係以1¾2 / Pd - C進行。 根據本發明所得之較佳式la化合物其中ri、R2及R4爲甲. 基’且R3及R5爲氫(即2,3,5 -三甲基吡啶)》 相較於已知技藝,本發明方法具諸多優點,例如: (1)保護態的式烯胺畈可在常壓下製,不須在高整是 中進行;及 經濟部中央標準局員工消費合作社印策 (請先閱讀背面之注意事項再一填寫本頁) > (U )中間物式比/銅化合物具有發展潛力,例如,其可進 一步製備式Ίΐ)及ic。 本發明之另一目的係提供一種製備式lb化合物及其衍生 物之方法 45099 . DOC ^ 本紙張尺度通用中國國家標準(CNS ) 21GX 297公釐) 434206 A7 B7 五、發明説明(81T rr A7 B7 V. Description of the invention (7) It should be carried out in benzene and with P_TSA as catalyst. In step (2), the preferred reagent that can supply poland cations is propionium cations, such as propane gas or liver propionate. Step 3 (preferably in the presence of a deacidifying agent and optionally in toluene or methyl tertiary butyl) It is carried out in the presence of an ether, and preferred examples of the deacidifying agent are pyridine, propylene oxide or tertiary amine. The alkylation reaction is preferably performed at 40 ° C., most preferably at 50 ° C. The preferred examples of the strong base used in the intramolecular cyclization reaction in step (3) are sodium hydride and t-butanol. Or sodium amidate, and the intramolecular cyclization is preferably carried out in a bulk agent; the hydration reaction of step 较佳 is preferably carried out in the presence of -xin (: 03 / propyl net, and more The calcination reaction with a dialkyl sulfuric acid is preferred. Step ⑸ is preferably carried out at 110-130 ° C, and is most preferably performed at 120 ° C. Among them, the preferred phosphorus compounds are phosphorus and chlorine and scale. And the hydrogenolysis reaction of step ⑹ is preferably carried out in the presence of a deacidifying agent, the preferred examples of the deacidifying agent are ammonia and ethanol, and the gasolysis reaction is preferably carried out at 1¾ 2 / Pd-C. According to the present invention, Preferred compounds of formula la in which ri, R2 and R4 are methyl groups and R3 and R5 are hydrogen (ie, 2,3,5-trimethylpyridine). Compared with known techniques, the method of the present invention has many advantages, For example: (1) Protected formula enamines can be made under normal pressure, and do not need to be carried out in the middle of the whole process; and the policy of employee consumer cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please first (Please read the notes on the back of the page and fill in this page again.) ≫ (U) The intermediate formula ratio / copper compound has development potential, for example, it can further prepare formula Ίΐ) and ic. Another object of the present invention is to provide a preparation formula Method for lb compound and its derivatives 45099. DOC ^ This paper is in accordance with the Chinese National Standard (CNS) 21GX 297 mm) 434206 A7 B7 V. Description of the invention (8

其中’ R1、R2及R4爲Q - C4 -烷基;R3爲OR31,其中RM爲 Q C4 -烷基;且R5爲氫、羥基及OP ( 〇 K 〇R5i )2,其中R”爲 甲基或乙基, 其包括下列步線: (1)式b比酮仡合物經氫化及以Hal P ( Ο ) ( 〇R5i )2 (其中Hal爲 鹵素,且RM爲甲基或乙基)進行磷醢化反應後,分別得到 式I羥基吡啶衍生物及式£_憐酯衍生物 OR31 r^〇31 OR”Where R1, R2 and R4 are Q-C4-alkyl; R3 is OR31, where RM is QC4-alkyl; and R5 is hydrogen, hydroxyl, and OP (〇K 〇R5i) 2, where R "is methyl Or ethyl, which includes the following steps: (1) the hydrogenated ketone adduct of formula b is carried out with Hal P (Ο) (〇R5i) 2 (where Hal is halogen and RM is methyl or ethyl) After the phosphating reaction, a hydroxypyridine derivative of the formula I and a pyridine derivative of the formula OR31 r ^ 〇31 OR were obtained, respectively. "

N^^OHN ^^ OH

八 ΟΡίόχΟί^、 (請先鬩讀背面之注意事項再|填寫本頁) 經濟部中央標準局員工消費合作社印裝 8 9 ⑵式i_化合物可視情況進一步還原得到式比咬街生物 (式lb,其中R1、R2及R4爲Ci - C4 -烷基;RJ爲OR31,其中Rsi 爲Q-C»-烷基:且R5爲氫) - OR31 ! ,R4 10 0 此方法獲得之式ϋ化合物可視情況進一步氡化得到式U 吡啶氧化物。八 ΟΡίόχΟί ^, (Please read the precautions on the back before filling in this page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 8 9 ⑵ 式 i_ Compounds can be further reduced according to the situation to obtain the formula than the bite street organism (Form lb, Where R1, R2, and R4 are Ci-C4 -alkyl; RJ is OR31, where Rsi is QC »-alkyl: and R5 is hydrogen)-OR31!, R4 10 0 Compounds of formula 获得 obtained by this method may be further processed as appropriate. To give a pyridine oxide of formula U.

本紙張尺度通用中國國家標準(CNS ) Α4規格(210·Χ297公釐) Q) 4 4The paper size is in accordance with the Chinese National Standard (CNS) A4 specification (210 · × 297 mm) Q) 4 4

CL A7 B7 經濟部中央標準局員工消費合作杜印裝 五、發明説明(9 )CL A7 B7 Consumption cooperation of employees of the Central Bureau of Standards of the Ministry of Economic Affairs Du Yinzhuang 5. Description of the invention (9)

R4 此方法之步驟⑴較佳係於四氫11夫喃中進行,且其中氫化 反應較佳係以NaH進行3步騍⑵較佳係以選έ鋰、鈉、坪 或飲之金屬於液氨中進行還原反應,其中較佳者爲經,且 此步骤中可視「‘晴況加入質子供給試劑如第三丁醇等。該進 一步之氧化反應較佳係以過氧化氫於醋酸水溶液中進行。 得到之式JJj,比啶氧化物可再經本身已知方法轉換成如下 式之經卣甲基取代之曱氧基吡啶。 OR31R4 The steps of this method are preferably carried out in tetrahydro 11-furan, and the hydrogenation reaction is preferably carried out with NaH for 3 steps. The most preferred method is to select lithium, sodium, ping or drinking metals in liquid ammonia. The reduction reaction is carried out in the medium, and the preferred one is Jing. In this step, "proton supply reagents such as tertiary butanol can be added in sunny conditions. This further oxidation reaction is preferably performed with hydrogen peroxide in an acetic acid aqueous solution. The obtained formula JJj, pyridyl oxide can be converted into fluorenylmethyl substituted pyroxypyridine of the following formula by a method known per se. OR31

(其中X爲鹵素,R2、R31及R4如前述定義)。 此方法之較佳實施例爲2,3,5 -三甲基-.4 -甲氧基u比咬(即 式lb,其中Ri、R2及R4爲> 基;R3爲甲氧基且R5爲氫者)之· 製備。 Λ ’ 由此方法,獲得之2,3 ,5-三甲基-4 -甲氧基吡啶可視情況 進一步氧化得到2,3,5 -三甲基-4 -甲氧基吡啶氧化物。而 得到之2,3 ,5 -三甲基-4-甲氧基吡啶氧化物可再轉換成奥 米咪峻合成所需之起始物質2 -氣甲基'3 ,5 -二甲基-4-甲氧 基比淀,此種轉換的詳細操作過程已揭示於歐洲專利Ε Ρ 0 45 3 9 9. DOC -* 12 — 本紙張尺度適用中國國家橾準(CNs ) A4規格(21 〇 X 297公釐) ---------裝---'--l·訂 (請先閣讀背面之注意事項_«填寫本頁) A7 B7 R3 -R4(Where X is halogen, R2, R31 and R4 are as defined above). A preferred embodiment of this method is the ratio of 2,3,5-trimethyl-.4-methoxyl u (ie formula lb, where Ri, R2 and R4 are >groups; R3 is methoxy and R5 Those who are hydrogen) of · Preparation. Λ 'By this method, the 2,3,5-trimethyl-4-methoxypyridine obtained may be further oxidized according to circumstances to obtain 2,3,5-trimethyl-4-methoxypyridine oxide. The 2,3,5-trimethyl-4-methoxypyridine oxide obtained can then be converted into the starting material 2-aminomethyl'3,5-dimethyl- 4-methoxy ratio lake, the detailed operation process of this conversion has been disclosed in the European patent EP 0 45 3 9 9. DOC-* 12 — This paper size applies to China National Standards (CNs) A4 specification (21 〇X 297mm) --------- install ---'-- l · order (please read the precautions on the back first_ «fill out this page) A7 B7 R3 -R4

434206 五、發明説明(10 005 129( 1979)中。 本發明之另·一目的係提供-~稽制体j 1〜人& 艰製備式Ic化合物及其衍生 物之方法434206 V. Description of the invention (10 005 129 (1979). Another object of the present invention is to provide a method for preparing a compound of formula Ic and its derivatives, a method for producing a compound j 1 to a human.

Ic 其中,R1、R2犮R4爲C! - C4 -烷基;r3爲〇r31或_素其 中R31爲C, - C4 -¾基;且R5爲自素。 其包括下列步驟: 將式汰吡酮化合物與自化試劑反應,得到式1單齒化產 物與式2_双自化產物的混合物 I.^ (請先閱讀背面之注意事項再|填寫本頁)Ic wherein R1, R2, and R4 are C! -C4-alkyl; r3 is or31 or R-wherein R31 is a C, -C4-¾ group; and R5 is a self-prime. It includes the following steps: reacting a compound of formula Tpyridone with an autochemical reagent to obtain a mixture of the monodentate product of Formula 1 and the product of 2-bichemical product I. ^ (Please read the precautions on the back before | fill in this page )

OR31 XOR31 X

12 7 (其中X爲由素,R1、R2、R3i及R4如前所定義)β 訂 經濟部中央標隼局員工消費合作社印製 此方法係在較溫和條如室溫至l〇〇°C下,較佳爲60 - 8(5 °C下反應,且其中矣佳之鹵化試劑爲氣化試劑,如p〇ci3, SOCl2或R' R",P( 〇 ) Cl (其中R1與R"分別爲烷基或苯基)。 其中生成之混合物比例依所操作的反應條件而有所不同 ,並其可藉傳統之分餾方式分離之》 式1化合物可進一步進行氫解反應得到式化合物12 7 (where X is defined by prime, R1, R2, R3i, and R4 are as previously defined) β Order Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs The reaction is preferably 60-8 (5 ° C, and the best halogenating reagent is a gasification reagent, such as p0ci3, SOCl2 or R'R ", P (〇) Cl (where R1 and R " respectively It is an alkyl group or a phenyl group). The proportion of the mixture produced varies according to the reaction conditions. The compound of formula 1 can be further hydrogenolyzed to obtain a compound of formula

.DOC -13 本紙張尺度適用中國國家橾隼(CNS ) A4規格(210X297公釐) 434206 A7 B7 五、發明説明(11 OR31.DOC -13 The size of this paper is applicable to China National Standard (CNS) A4 (210X297 mm) 434206 A7 B7 V. Description of the invention (11 OR31

OR31OR31

R4 12 此氫解反應較佳係以Η2 / P d · C於乙醇及液氨中進行。 此方法較佳實施例之反應產物爲2 -氣-3 5 6 -=田计 - ’ 7 ~ 丫暴 ' 4 - 甲氧基吡啶。此產物經氫化獲得之2,3,5 _三甲基_ 4 _甲氧 基吡啶可依前述已知方法製成奥米咪唑合成所需之起妒物 質2 -氣甲基-3 ,5 -二甲基-4-甲氧基吡啶。 本發明之另一目的爲製備式Id化合物及其衍生物之方法 R3R4 12 This hydrogenolysis reaction is preferably carried out with Η 2 / P d · C in ethanol and liquid ammonia. The reaction product of the preferred embodiment of this method is 2 -Ga-3 5 6-= Tian Ji-′ 7 ~ Ya Bao '4 -methoxypyridine. The 2,3,5_trimethyl_4_methoxypyridine obtained from the hydrogenation of this product can be made into the enantiomeric substance 2-omethyl-3,5- Dimethyl-4-methoxypyridine. Another object of the present invention is a method for preparing compounds of formula Id and derivatives thereof R3

(請先閏讀背面之注意事項再,填寫本頁) •棄. b 經濟部中央標準局員工消費合作社印裝 ,R4 Id 其中,R1爲自甲基,胺甲基,羥甲基,腈基或羰胺基;R2 及R4爲C丨-C4-烷基;R3爲0R3>(其中R3丨爲Ci_C4烷基);且 R5爲氫。 . . 其係以酮衍生物爲起始物並利用其衍生之哌噚衍生物作w 爲關鍵中間、原料,#將其衍生的吡酮衍生物經過適當之官 能基轉換择到式Id之吡啶衍生物。其詳細步驟如下: (1)將下式1^_之起始物(其可參考述於"有機合成(Organic Syntheses )’卷70, 231 ( 1991 )"之方法將酮經由烷醯化得 到)與闺烷化物R6X (其中R6爲C, - C4 -烷基且X爲鹵素) 在鹼性下進行氧烷化作用得到式1化合物; 14 - -a Γ 本紙張尺度適用中國國家操準(CNS)ί\4規格(2lOX297公t) 434206 A7 B7 五、發明説明(12 )(Please read the notes on the back before filling out this page) • Discard. B Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, R4 Id, where R1 is from methyl, aminemethyl, hydroxymethyl, nitrile Or carbonylamino; R2 and R4 are C1-C4-alkyl; R3 is OR3> (where R3 丨 is Ci_C4 alkyl); and R5 is hydrogen. .. It uses ketone derivatives as starting materials and uses its derived piperidine derivatives as w as key intermediates and raw materials. # The derived pyrone derivatives are converted to pyridine of formula Id by appropriate functional group conversion. derivative. The detailed steps are as follows: (1) The starting material of the following formula 1 ^ _ (which can be referred to described in " Organic Synthesis (Organic Syntheses) 'Volume 70, 231 (1991) " Obtained) and alkane compound R6X (where R6 is C, -C4 -alkyl and X is halogen). Oxyalkylation under basic conditions to obtain the compound of formula 1; 14--a Γ This paper size is applicable to Chinese national standards (CNS) ί \ 4 specifications (2lOX297 male t) 434206 A7 B7 V. Description of the invention (12)

OH R2OH R2

14 13 ⑵將式触合物與二乙基草酸g§在驗性下進行 同時合環生产式也,底哜酸與式瓜哜酯. 醯化且14 13 ⑵ The compound of the formula and diethyloxalic acid g§ are tested under the same conditions. At the same time, the ring is also produced to produce formula, acetic acid and formula citrate.

及 H02c,、〇 r〇2cAnd H02c, 〇 r〇2c

16 (請先閲讀背面之注意事項再一填寫本頁) 15 ⑶將式见略’酿於高壓釜中加熱進行胺化並同時醯胺 化得到式12_吡酮醯胺衍生物 R2iV H2N(0)C 人 R4 17 經濟部中央標準局員工消費合作社印製 OR 3116 (Please read the precautions on the back and fill in this page again.) 15 ⑶ The formula is omitted. Brew in an autoclave and heated for amination and simultaneous amination to obtain the formula 12_pyridone amide derivative R2iV H2N (0 C) R4 17 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs OR 31

R4 18 Η ⑷將式IZj^比酮醯胺衍11生物於鹼性下烷基化生成式1B 基化產物R4 18 Η ⑷ alkylates the formula IZj ^ ketoamine amine derivative 11 under alkaline to form the alkylated product of formula 1B

酬0)C八N (R31 爲 C! - C4 -境基) ⑸將式坡基化產物以脱水劑處理得到高產率之式!£_Remuneration 0) C eight N (R31 is C!-C4-environment-based) ⑸ The slope-based product is treated with a dehydrating agent to obtain a high yield formula! £ _

45899.DOC 本紙張尺度適用中國國家標準(CNS > A4规格(210X 297公釐) 434206 A7 B7 五、發明説明(u 腈衍生物 OR3145899.DOC This paper size applies to Chinese national standards (CNS > A4 size (210X 297 mm) 434206 A7 B7 V. Description of invention (u Nitrile derivative OR31

R4 19 ; ⑹式1_2_產物可视情況經觸媒催化還原得到式& 合物 曱胺化 諳 先 聞 讀 背 項 OR31R4 19; The product of ⑹Formula 1_2_ can be obtained through the catalytic reduction of the catalyst to obtain the compound of formula & 曱 amination 谙 first heard read back term OR31

R4 H2Ns 頁 20 ⑺式甲胺化合物可視情況經重氮化與檢性水解得到 式21_化合物 . OR31R4 H2Ns Page 20 Benzene methylamine compound can be obtained by diazotization and detection hydrolysis to obtain compound of formula 21_. OR31

R4 'N 經濟部中央標準局員工消費合作社印製 OR31R4 'N Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economy OR31

HO. * 21 (8)式21化合物可視情況經鹵化反應得到式22化合物 ,R4 22 — (其中X爲自素,且R2、R31及R4如前述定義)。 其中氫化、重氮化水解與南化乃已知技藝(見DE 3840372 本紙張尺度適用中國國家標準(CNS ) Α4说格(21〇:<297公釐) 434206 A7 B7 五、發明説明(l4 ) 經濟部中央標準局員工消費合作社印製 (1988 )) 〇 其中’步驟⑴中之圉烷化物較佳爲溴乙烷,且該氧烷化 作用較佳係以Κζ(:〇3爲鹼性化合物及於两酮存在下進行。 步驟⑵中哌啤合成所使用之鹼性化合物之較佳實例爲乙醇 納、特丁醇鉀或胺化鈉,反應較佳爲於乙醇鈉/乙醇中進 行。步驟⑶較佳係以氨於乙醇中進行。步驟⑷中之燒基化 反應較佳係以二僉基硫酸並以K2C〇3爲鹼性化合物及於丙 網存在下進行"。步驟⑸中脱水劑之實例包括三氟醋酸酐與-外匕啶之混合試劑、五氧化二磷、磷醯氣、五氣化磷、二甲 基甲醯胺/酸.、二甲基甲醯胺二甲縮醛及亞硫醯氣拳,較 佳者爲三氟醋酸酐與吡啶之混合試劑,其較佳之反應溫度 爲0C至室溫’且反應可於二氣甲烷中進行。 此方法之較佳反應產物爲3,5-二甲基-4-甲氧基吡啶- 2-腈(即式Μ中R1爲CN,R2,及R4爲甲基,R3爲甲氧基,五R5、 爲氨者)。 該3,5 -二甲基-4 ·甲氧基吡啶-2 -腈如前述可視情況經氫 化、重氮化及水解得2 -氣甲基-3,5 -二1 i - 4 甲氧基吡之 ’且其可再利用前述已知方法經氯化作用得到奥米咪唑之 重要合成起始物質3 -氣曱基-3,5 -二甲基-4 -甲氧基吡啶。 實施例 , 基-3 -芊胺某丁烯酸乙酯 將單甲基乙醯乙酸乙酯(28.8克,0.2莫耳)、笮胺基(21.4克, 002莫耳)與對甲苯磺酸單水合物(0.4克,0.02當量)依序加入 苯溶劑(300毫升)中,然後迴流加熱並以Dean - Stark裝置收 本紙張尺度適用中國國家標準(CNS ) Μ規格(210X297公釐) 請 先 閱 讀 背 面 之 注 項 填 寫 本衣 頁 訂 ^34206 A7 B7 經濟部中央標牟局貝工消費合作杜印策 五、發明説明(is) 集共沸蒸出的水份,大約3.5小時後水分不再析出。所得溶 液經放冷後以水洗二次,有機層經無水硫酸鈉乾燥與濃縮 。殘留液進行眞空蒸餾得到標的化合物(41.8克,99.7%)。LH NMR (CDC13, 200 MHz) 9.67 (brS, 1H), 7.20 - 7.40 (5H), 4.45 (2H, J = 6.2Hz, 2H), 4.17 (g, J = 7.2Hz, 2H), 1.95 (S, 3H), 1.83 (S, 3H), 1.31 (t, J = 7.2Hz, 3H)« 2 -甲基-3 -丙醯化芊胺基-丁烯酸乙酯 將2 -甲基,3 -爷:胺基-丁烯酸乙酯(44.7克,0.204莫耳)與吡 啶(20,2克,0.255,莫耳)依次加入甲苯(70毫升)中,接著滴入-含丙醯氣(18.9克,0_204莫耳)於30毫升甲苯的溶液。然後迴 流加熱隔夜,’所得溶液經過濾後進行濃縮。殘留物以乙酸 乙酯稀釋,然後經水洗,乾燥與濃縮得標的化合物(56 6克, 96% ) = NMR (CDC13, 200 MHz) 7.10 - 7.25 (m, 5H), 4.97 (d, J = 14.30 Hz, 1H), 4.24 (d, J = 14.30 Hz, 1H), 2.40 (g, J = 7.0 Hz, 1H), 2.10 (g, J = 7.0 Hz, 1H), 1.85 (S, 3H), 1.70 (S, 3H), 1.20 (t, J = 7.0 Hz, 1.5H), 1.14 (t, J = 7.0 H& 1.5H)。此外,2_甲基-3-芊胺基-丁烯酸乙酯/丙醯氣 與過量(10〜20體積比)的環氧丙烷在甲基第三丁基醚溶劑 中加熱至5〇。(;並維持數小.時,接著進行^農縮與眞空加熱見 燥後亦可生成標的化合物。 N -芊基-4-羥基- 3~Γ5,6 -三甲基-2-吡酮 將2 -甲基3 -丙醯化芊胺基-丁烯酸乙酯(53.8克,0.196莫耳) 與60%氫化鈉(22克,2.8當量)依序加入冰冷的乾燥苯溶劑 (240毫升)+,然後迴流加熱8小時。所得溶液在冰浴下以 6Ν HC1調至微酸性,所析出白色固體經由過濾與乾燥得到 標的化合物(41 克,86% )熔點 263°C。NMR (6d - DMSO, 200 MHz) 本紙張尺度適用中國國家標準(CNS > A4規格(2〗〇><297公釐) ---------裝— (請先閲讀背面之注意事項再一填寫本頁) 訂 經濟部中央標準局員工消费合作社印聚 434206 A7 B7 五、發明説明(16 ) 9.24 (S, 1H) ,7.00 - 7.30 (m, 5H), 5.30 (sb, 2H), 2.18 (S, 3H), 1.94 (S, 6H); Ms (m / e,rel intensity) 243.2 (M+,100),228.2 (5) ;元素分析(Ci5hi7N〇2 ) :計算値 C,74·〇7; H, 7.00; N,5.76;實測値 C,74.01; H,7.01; N, 5.80 » N -苄基·4 -甲氳基-3,5,6-三甲基-2-吡賙 將Ν-节基-4-經基-3,5,6-三甲基-2-峨_( 15克,0.062莫耳) ,無水碳酸鉀(17克,0.12莫耳)與二甲基硫酸(9.3克,0.074莫耳) 依次加入丙酮(300毫升)中,然後迴流加熱隔夜,所得溶 液經放冷後經過濾、濃縮,殘留物以乙酸乙酯稀釋,再經-水洗、乾燥與濃縮得到標的化合物(14.66克,92% ),其爲白 色粉末,熔點 169°C。屯 NMR (CDC13, 200 MHz) 7.10 7.35 (m,5Η), 5.42 (sb, 2H), 3.75 (S, 3H), 2.23 (S, 3H), 2.16 (S, 3H), 2.04 (S, 3H); Ms (m / e, rel intensity) 257.2 (M+, 100)。 4 -甲氧基-3,5、6·三甲基-2-吡酮 於氫化瓶中依序加入Ν·-芊基-4 -甲氧基-3,5,6 -三甲基-、 2-吡_(23克,0.089莫耳)、冰醋酸(150毫升)與l〇%Pd-C(2克) ’然後在60 Psi錶壓的氩氣壓力下搖晃丨2小時。所得溶液經 由Celite過濾後進行減壓考縮,殘留物以f0%碳酸鉀水溶良 調至微鹼性,析出的固體經過濾、水洗與眞空乾燥得到標 的化合物(M.6克,),其爲一白色粉末,熔點194X: »屮 NMR (CDC13, 200 MHz) 13.04 (brS, 1H), 3.73 (S, 3H), 2.31 (S, 3H), 2.08 (S, 3H), 1.98 (S,3H); Ms (m / e, rel intensity) 167.1 (M+, 100),152,1 (2);元素 分析((:9叶以〇2):計算値 c,64.67; H,7,78; N,8.38;實測値 C,64.94; H, 7.87; N, 8.45 = 2,4 -二氣-3,5,6 -三甲基吡啶與2,4 -二溴-3, 5,6 -三甲基 45&99*DOC 19 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ---------k-- (請先閲讀背面之注意事項再,填寫本頁) 訂 434206 經濟部中央標隼局員工消費合作社印製 A7 B7 五、發明説明(l7 ) 叶匕淀 將4 -甲氧基-3, 5,6 -三甲基-2 -吡酮(8克,0.048莫耳)與鱗 酿氣(7.34克,0.048莫耳)在Π0 C下加熱3〇分鐘;所得途液放 冷後以二氣甲院與碎冰稀釋’有機層分出後以1〇〇/。碳酸钟 調至微鹼性’然後再經水洗、乾燥與濃縮得到2,4 _二氣_ 3,5,6 三甲基吡啶(8.2克,90% ),其爲白色粉末結晶,熔點 66 - 68。(:。Ή NMR (CDC13, 200 MHz) 2.42 (S,3H),2.36 (S,3H),2.24 (S, 3H) ^若以磷磕溴(13.8克,0.048莫耳)取代磷醯氣作同樣操作-得到2,4 -二溴-3,5,6 -三甲基u比喊(12.7克,95%),落點50- 52 eC。Ή NMR (CDC13, 200 MHz) 2.54 (S,6H), 2.35 (S,3H)。 2,3 , 5 -三甲基吡啶 將2,4 -二氣-3,5,6 -三曱基吡啶(9.5克,0.05莫耳)或2,4-二溴-3,5,6 -三甲基峨淀(14克,0.05莫耳)溶於内含i - 3wt%赵 觸媒的乙醇(1〇〇毫升)及氨水(10毫升)的混合液中,然後在' 錶壓40 Psi的氫氣壓力下搖晃直到反應終了(大約5小時), 過濾除去觸媒,濾液經濃縮得到氣化銨(或溴化銨)與 2,3 , 5 -三甲基吡啶之混合物,其以三氯f烷泡洗並過濾、 濾液經水洗、乾燥與濃縮得到2,3,5 -三甲基吡啶(5.8>克, 95%)。其爲1 油狀液' 屯 NMR (CDC13, 200 MHz) 8.14 (S,1H),7.22 (S, 1H),2.44 (S,k),2.25 (S,3H), 2.23 (S,3H)。所得結果與標準品的 光譜相同。 2-二乙基磷酯基-4 -甲氧基-3,5,6 -三甲基吡啶 在氮氣下加入60%氫化鈉(0.263克,6.59毫莫耳)於50毫升瓶 中,以5毫升四氫咬喃洗去油質並用針抽出,接著再注入 45B99 .DOC — 20 - 本紙張尺度適用中國國家標準(CNS ) A4规格(210X297公釐) I I I 111 訂r (請先閲讀背面之注意事項-*壤寫本頁) 434206 A7 B7_ 五、發明説明(is ) 四氫吱喃(30毫升)及4 -甲氧基-3,5,6 -三曱基_ 2 _峨納(lo 克,5.99毫莫耳)’在室溫下授拌約30分鐘後再注入醋化試劑 二乙基磷酯醯氣(diethyiphosPhoryl chloride)並授拌隔夜°然後 減壓·抽去四氫吱喃’殘液以100毫升說氧化納水溶液稀 釋後再以三氣甲坑萃取,有機層再經水洗、乾燥、濃縮得 標的化合物(1.82克,100% )’其爲黏稠油狀物’'經眞空乾燥 後可逞行下一步 k 應。lH NMR (CDC13, 200 MHZ) 4·41 (g,J = 7·2 1¾ 4H),3.74 (S,3H),2.38 (S,3H),2.15 (S,3H),1.43 化 J = 7.2 Hz, 6H)。 2.3.5 -三甲基-4-甲氧基吡啶 方法A : 爲確保液態氨無水,先將液氨冷凝在250毫升的三頸瓶中 ,再加入約0.1克金屬鋰,此時液態氨呈藍色,接著移去冷 浴使液氨揮發並再度冷凝至另一個1⑻毫升三頸瓶中收集 約50毫升液氨。接著滴入含2 -二乙基磷酯基-4-甲氧基-3,5,6 -三甲基吡啶(5.54克,18.3毫莫耳)溶於14毫升四氫呋喃 的溶液,再加入預先稱好的金屬鋰(〇·381克,M.85毫莫耳), 溶液顏色由無色轉爲淡免以至橘紅。挽"4Ϊ 15分鐘後加入I 化接(2.96克,55.33宅莫耳)’並使液氨揮發掉。殘液加入1〇〇 毫升水後以'三氣甲"k萃取’萃取液經乾燥、濃縮得到油狀 物,其以管柱層析法分離,沖提溶劑是乙酸乙酯與正己烷 (1 : 5 ),依次得到2,3,5 -三甲基吡啶(〇·22克,10% ),及標 的化合物(0.97克,35%),其爲無色油狀液β ιΗ丽尺(CDC13, 200 MHz) 8,15 (S, 1H), 3.75 (S, 3H), 2.46 (S, 3H), 2.22 (S, 3H), 2.19 (S, 3H) » 以及4 -甲氧基-3,5,6 -三甲基-2-吡酮(0.46克,15% )。 .DOC - 21 — 表紙張尺度適用中國國家標準(CNS > A4現格(210X 297公釐> ~~ (請先閲讀背面之注意事項再I填寫本頁) 訂 經濟部中央標準局員工消費合作,社印裝 43420t A7 B7 五、發明説明(19 方法B : 請 聞 讀 背 之 注 意 事 項 L# 將2 -二乙基磷酯基_4_甲氧基-3,5,6 -三甲基吡啶(24克, 0.144莫耳)與磷醯氣(22.02克,0.144莫耳)(或在10 - 20體積比的 乾燥1,2_二氣乙烷存在下)在6〇_ 7〇。(:下加熱5小時;所得 溶液放冷後以三氣甲烷與碎冰稀釋,有機層分出後以1〇〇/0 碳酸鉀調至微鹼性,然後再經水洗、乾燥與濃縮得到2,4 二氣·3, 5,6 -三甲·基吡啶與2 -氣-3,5,6 -三甲基-4 -甲氧基 吡啶混合物將此混合物依2,4 -二氣-3,5,6 -三甲基吡啶 的氫解方式操作得到標的化合物與2,3,5 -三甲基吡啶的混 合物’再經由減壓分餾依次蒸出2,3 , 5 -三曱基吡啶(9.53克, 54.7%)與標的化合物(5.94克,27.3% )。 2,3,5 -三甲基-4 -甲氧基峨唉氧化物HO. * 21 (8) The compound of formula 21 may be halogenated to obtain the compound of formula 22, R4 22 — (wherein X is self-prime, and R2, R31 and R4 are as defined above). Among them, hydrogenation, diazotization, hydrolysis and southernization are known techniques (see DE 3840372, this paper size applies Chinese National Standard (CNS) A4) (21〇: < 297 mm) 434206 A7 B7 V. Description of the invention (l4 ) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (1988)) 〇The arkanide in step 较佳 is preferably bromoethane, and the oxyalkylation is preferably based on Kζ (: 〇3 as alkaline Compounds and in the presence of two ketones. Preferred examples of the basic compounds used in the synthesis of pipe beer in step ⑵ are sodium ethoxide, potassium t-butoxide or sodium amidate, and the reaction is preferably performed in sodium ethoxide / ethanol. Step (3) is preferably carried out with ammonia in ethanol. The calcination reaction in step (2) is preferably carried out with dioxosulfuric acid and K2CO3 as the basic compound in the presence of propylene network. "Step (2)" Examples of the dehydrating agent include a mixed reagent of trifluoroacetic anhydride and -exopyridine, phosphorus pentoxide, phosphine gas, phosphorus pentafluoride, dimethylformamide / acid, dimethylformamide dimethyl Acetal and sulfite gas punches, preferably a mixed reagent of trifluoroacetic anhydride and pyridine, which The preferred reaction temperature is from 0C to room temperature 'and the reaction can be carried out in methane. The preferred reaction product of this method is 3,5-dimethyl-4-methoxypyridine-2-nitrile (ie formula M (Where R1 is CN, R2, and R4 are methyl, R3 is methoxy, and penta R5 is ammonia). The 3,5-dimethyl-4 · methoxypyridine-2 -nitrile may be as described above. An important synthesis of 2-o-methyl-3,5-di-1 i-4 methoxypyridine through hydrogenation, diazotization, and hydrolysis, which can be reused by the previously known methods to obtain omimidazole through chlorination The starting material is 3-airino-3,5-dimethyl-4-methoxypyridine. Example, Ethyl-3 -amidoethyl butenoate ethyl monoethylacetate ethyl acetate (28.8 G, 0.2 mol), amido (21.4 g, 002 mol) and p-toluenesulfonic acid monohydrate (0.4 g, 0.02 equivalents) were sequentially added to the benzene solvent (300 ml), then heated under reflux and dean -The size of the paper received by the Stark device is in accordance with the Chinese National Standard (CNS) M specifications (210X297 mm). Please read the notes on the back and fill in this page. ^ 34206 A7 B7 Du Yinze V. Description of the invention (is) The azeotropically distilled water is collected. After about 3.5 hours, the water no longer precipitates. The resulting solution is cooled and washed twice with water, and the organic layer is dried and concentrated over anhydrous sodium sulfate. The residue was subjected to vacuum distillation to obtain the target compound (41.8 g, 99.7%). LH NMR (CDC13, 200 MHz) 9.67 (brS, 1H), 7.20-7.40 (5H), 4.45 (2H, J = 6.2Hz, 2H), 4.17 (g, J = 7.2Hz, 2H), 1.95 (S, 3H), 1.83 (S, 3H), 1.31 (t, J = 7.2Hz, 3H) «2 -methyl-3 -propanamidinate Ethyl-butenoate Ethyl 2-methyl, 3-ethyl: amino-butenoate (44.7 g, 0.204 mol) and pyridine (20,2 g, 0.255, mol) were added to toluene ( 70 ml), followed by instillation-a solution containing propanium (18.9 g, 0-204 mol) in 30 ml of toluene. It was then heated under reflux overnight, and the resulting solution was filtered and concentrated. The residue was diluted with ethyl acetate, then washed with water, dried and concentrated to obtain the target compound (56 6 g, 96%) = NMR (CDC13, 200 MHz) 7.10-7.25 (m, 5H), 4.97 (d, J = 14.30 Hz, 1H), 4.24 (d, J = 14.30 Hz, 1H), 2.40 (g, J = 7.0 Hz, 1H), 2.10 (g, J = 7.0 Hz, 1H), 1.85 (S, 3H), 1.70 ( S, 3H), 1.20 (t, J = 7.0 Hz, 1.5H), 1.14 (t, J = 7.0 H & 1.5H). In addition, 2-methyl-3-amidoamino-butenoic acid ethyl ester / propane gas and excess (10-20 volume ratio) propylene oxide were heated to 50 in a methyl tert-butyl ether solvent. (; And maintain the number is small. Then, after the ^ agricultural shrinkage and air heating, it can also be generated after the target compound. N-fluorenyl-4-hydroxy-3 ~ Γ5,6-trimethyl-2-pyridone will 2-Methyl 3-propionated amidino-butenoic acid ethyl ester (53.8 g, 0.196 mol) and 60% sodium hydride (22 g, 2.8 equivalents) were sequentially added to ice-cold dry benzene solvent (240 ml) +, Then heated at reflux for 8 hours. The resulting solution was made slightly acidic with 6N HC1 under ice bath, and the precipitated white solid was filtered and dried to obtain the target compound (41 g, 86%). The melting point was 263 ° C. NMR (6d-DMSO , 200 MHz) This paper size applies to Chinese national standards (CNS > A4 specifications (2〗 〇 > < 297 mm) --------- installation-(Please read the precautions on the back first (Fill in this page) Order the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 434206 A7 B7 V. Invention Description (16) 9.24 (S, 1H), 7.00-7.30 (m, 5H), 5.30 (sb, 2H), 2.18 ( S, 3H), 1.94 (S, 6H); Ms (m / e, rel intensity) 243.2 (M +, 100), 228.2 (5); Elemental analysis (Ci5hi7N〇2): Calculate 値 C, 74 · 07; H, 7.00; N, 5.76; Measured 値 C, 74. 01; H, 7.01; N, 5.80 »N-benzyl · 4-methylamidino-3,5,6-trimethyl-2-pyridinium will be N-benzyl-4-meryl-3,5, 6-Trimethyl-2-E- (15 g, 0.062 mol), anhydrous potassium carbonate (17 g, 0.12 mol) and dimethyl sulfate (9.3 g, 0.074 mol) were added in order acetone (300 ml) Then, the solution was heated under reflux overnight. After cooling, the resulting solution was filtered and concentrated. The residue was diluted with ethyl acetate, washed with water, dried, and concentrated to obtain the target compound (14.66 g, 92%), which was a white powder. 169 ° C. Tun NMR (CDC13, 200 MHz) 7.10 7.35 (m, 5Η), 5.42 (sb, 2H), 3.75 (S, 3H), 2.23 (S, 3H), 2.16 (S, 3H), 2.04 (S, 3H); Ms (m / e, rel intensity) 257.2 (M +, 100). 4-Methoxy-3,5,6 · trimethyl-2-pyridone was added to the hydrogenation bottle in order. --Amidino-4 -methoxy-3,5,6-trimethyl-, 2-pyridine (23 g, 0.089 mol), glacial acetic acid (150 ml) and 10% Pd-C (2 G) 'Then shake at argon at 60 Psi for 2 hours. The resulting solution was filtered through Celite and subjected to reduced pressure. The residue was adjusted to slightly alkaline with f0% potassium carbonate in water. The precipitated solid was filtered, washed with water, and dried to obtain the target compound (M.6 g,), which is A white powder, melting point 194X: »屮 NMR (CDC13, 200 MHz) 13.04 (brS, 1H), 3.73 (S, 3H), 2.31 (S, 3H), 2.08 (S, 3H), 1.98 (S, 3H) ; Ms (m / e, rel intensity) 167.1 (M +, 100), 152.1 (2); Elemental analysis ((: 9 leaves to 0 2): Calculate 値 c, 64.67; H, 7, 78; N, 8.38; Found 値 C, 64.94; H, 7.87; N, 8.45 = 2,4-digas-3,5,6-trimethylpyridine and 2,4-dibromo-3,5,6-trimethyl 45 & 99 * DOC 19-This paper size applies to China National Standard (CNS) A4 (210X297 mm) --------- k-- (Please read the precautions on the back before filling in this page) Order 434206 A7 B7 printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the Invention (l7) Ye Diandian will be 4-methoxy-3, 5,6-trimethyl-2-pyrone (8 grams, 0.048 moles) and scale fermentation gas (7.34 g, 0.048 moles) were heated at Π0 C for 30 minutes; Erqi Jiayuan was diluted with crushed ice. The organic layer was separated and adjusted to 100% with carbonic acid. Then it was washed with water, dried, and concentrated to obtain 2,4_ 二 气 _ 3,5,6. Methylpyridine (8.2 g, 90%), which is a white powder crystal, melting point 66-68. (: : NMR (CDC13, 200 MHz) 2.42 (S, 3H), 2.36 (S, 3H), 2.24 (S , 3H) ^ If Phosphonium bromide (13.8 g, 0.048 moles) is used instead of Phosphonium gas to obtain the same operation-2,4-dibromo-3,5,6-trimethyl u ratio (12.7 g, 95 %), Falling point 50- 52 eC. Ή NMR (CDC13, 200 MHz) 2.54 (S, 6H), 2.35 (S, 3H). 2, 3, 5-trimethylpyridine 2,4-digas- 3,5,6-trimethylpyridine (9.5 g, 0.05 mole) or 2,4-dibromo-3,5,6-trimethylether (14 g, 0.05 mole) is dissolved in i -3wt% Zhao catalyst in a mixture of ethanol (100 ml) and ammonia (10 ml), and then shake under the hydrogen pressure of 40 Psi gauge until the end of the reaction (about 5 hours), filter to remove the catalyst The filtrate was concentrated to obtain a mixture of vaporized ammonium (or ammonium bromide) and 2,3,5-trimethylpyridine. Chlorofane was bubble-washed and filtered, and the filtrate was washed with water, dried, and concentrated to obtain 2,3,5-trimethylpyridine (5.8> g, 95%). It is 1 oily liquid tun (CDC13, 200 MHz) 8.14 (S, 1H), 7.22 (S, 1H), 2.44 (S, k), 2.25 (S, 3H), 2.23 (S, 3H). The results obtained are the same as those of the standard. 2-Diethylphosphoryl-4 -methoxy-3,5,6-trimethylpyridine Under nitrogen, add 60% sodium hydride (0.263 g, 6.59 mmol) to a 50 ml bottle with 5 The milliliter of tetrahydrobitan is used to wash off the oil and extract it with a needle, and then inject 45B99 .DOC — 20-This paper size applies to China National Standard (CNS) A4 (210X297 mm) III 111 Order r (Please read the note on the back first) Matters- * soil write this page) 434206 A7 B7_ V. Description of the invention (is) Tetrahydroanal (30 ml) and 4-methoxy-3,5,6-triamyl _ 2 _ Ana (lo g , 5.99 millimolar) 'After incubation at room temperature for about 30 minutes, inject the acetic acid reagent diethyliphosphine thoron gas (diethyiphosPhoryl chloride) and incubate overnight ° and then depressurize and extract the tetrahydrocran' residue The solution was diluted with 100 ml of sodium oxide aqueous solution, and then extracted with Sanqijiakeng. The organic layer was washed with water, dried, and concentrated to obtain the target compound (1.82 g, 100%). 'It is a viscous oil.' Proceed to the next step. lH NMR (CDC13, 200 MHZ) 4.41 (g, J = 7.2 1¾ 4H), 3.74 (S, 3H), 2.38 (S, 3H), 2.15 (S, 3H), 1.43 J = 7.2 Hz , 6H). 2.3.5-Trimethyl-4-methoxypyridine Method A: To ensure that the liquid ammonia is anhydrous, first condense the liquid ammonia in a 250 ml three-necked flask, and then add about 0.1 g of lithium metal. Blue, then remove the cold bath to volatilize the liquid ammonia and condense again into another 1⑻ml three-necked flask to collect about 50 ml of liquid ammonia. Next, a solution containing 2-diethylphosphono-4-methoxy-3,5,6-trimethylpyridine (5.54 g, 18.3 mmol) in 14 ml of tetrahydrofuran was added dropwise, and then weighed in advance For good metallic lithium (.381 g, M.85 mmol), the color of the solution changed from colorless to light or even orange-red. After 4 minutes and 15 minutes, add hydrazine (2.96 g, 55.33 mol) and let the liquid ammonia evaporate. The residue was added with 100 ml of water, and the extract was dried and concentrated to obtain an oily substance, which was separated by column chromatography. The extraction solvent was ethyl acetate and n-hexane ( 1: 5), 2,3,5-trimethylpyridine (0.22 g, 10%) and the target compound (0.97 g, 35%) were obtained in sequence, which is a colorless oily β βιι ruler (CDC13 , 200 MHz) 8,15 (S, 1H), 3.75 (S, 3H), 2.46 (S, 3H), 2.22 (S, 3H), 2.19 (S, 3H) »and 4 -methoxy-3, 5,6-trimethyl-2-pyridone (0.46 g, 15%). .DOC-21 — Applicable to Chinese National Standards (CNS > A4 now (210X 297mm) ~~ (Please read the precautions on the back before filling in this page). Order the staff of the Central Bureau of Standards of the Ministry of Economy Cooperative, printed by 43420t A7 B7 V. Description of the invention (19 Method B: Please read the notes on the back L # The 2-diethylphosphoryl group_4_methoxy-3,5,6 -trimethyl Pyridyl (24 g, 0.144 mol) and phosphonium gas (22.02 g, 0.144 mol) (or in the presence of 10-20 volume ratio of dry 1,2 digas ethane) at 60-7. (: Heating for 5 hours; after cooling, the resulting solution is diluted with three gas methane and crushed ice, the organic layer is separated to make it slightly alkaline with 100/0 potassium carbonate, and then washed with water, dried and concentrated to obtain 2 , 4 Digas · 3,5,6-trimethylpyridine and 2-Ga-3,5,6-trimethyl-4-methoxypyridine mixture. This mixture is based on 2,4-Digas-3, The hydrogenolysis of 5,6-trimethylpyridine was used to obtain a mixture of the target compound and 2,3,5-trimethylpyridine ', and then 2,3,5-trimethylpyridine (9.53 G, 54.7%) with standard Compound (5.94 g, 27.3%) of 2,3,5 - trimethyl - 4 - methoxy Bauer Oh oxide

經濟部中央樣準局員工消費合作.杜印1L 2,3 ,5-三甲基-4 -甲氧基吡啶(3.2克,20毫莫耳)溶在1〇毫 升冰醋酸中,然後滴入5:0毫升30%過氧化氫水溶液,先在 3〇°C下攪拌1小時,然後升至7(TC攪拌5小時,最後升至90 1後加入少量的把/竣粉以破壞過量的過氧化氫,待回至 室溫後濃縮抽去溶劑,殘留液加曱苯蹬#濃縮以除去殘乱 水份得標的化合物(2.84克,δ5%)。熔點35°C,β NMR (CD03, 200 MHz) 8.2a(S,1H),1.80 (S,3H),2‘50 (S,3H),2.25 (S,6H),所得結 果與標準品的光譜相同。 2 -甲基-1 -戍烯-1 -乙氧基-3 -酮 將起始物2 -甲基-1-戊烯-1-醇-3-酮(76克,0.67莫耳)溶於 丙酮(1500毫升),然後依次加入溴乙烷(209克,1.92莫耳)與 無水碳酸钾(115克,〇‘83莫耳)將此混合物加熱迴流34小時,Consumption cooperation among employees of the Central Bureau of Standards, Ministry of Economic Affairs. Du Yin 1L 2,3,5-trimethyl-4-methoxypyridine (3.2 g, 20 mmol) was dissolved in 10 ml of glacial acetic acid, and then dropped 5: 0 ml of 30% hydrogen peroxide aqueous solution, first stirred at 30 ° C for 1 hour, then rose to 7 (TC for 5 hours, and finally rose to 90 1) and then add a small amount of powder to complete the process. Hydrogen oxide. After returning to room temperature, the solvent was concentrated and the solvent was removed. The residual solution was concentrated by adding benzophenone # to remove the residual compound (2.84 g, δ5%). Melting point 35 ° C, β NMR (CD03, 200 MHz) 8.2a (S, 1H), 1.80 (S, 3H), 2'50 (S, 3H), 2.25 (S, 6H). The results obtained are the same as those of the standard. 2-methyl-1-戍Ene-1 -ethoxy-3 -one The starting material 2-methyl-1-penten-1-ol-3-one (76 g, 0.67 moles) was dissolved in acetone (1500 ml), then Ethyl bromide (209 g, 1.92 moles) and anhydrous potassium carbonate (115 g, 0'83 moles) were added and the mixture was heated under reflux for 34 hours.

, DOC 本紙張尺度逋用中國國家標隼(CNS ) A4规格{ 21 ο X 297公釐) 434206 A7 B7 經濟部中央標準局員工消費合作社印复 五、發明説明(20 ) 所得溶液經放冷過濾,滤液濃縮後以水稀釋,.稀釋液以乙 酸乙酯萃取二次,有機層以稀的碳酸鉀水溶液洗與水洗之 ,然後經乾燥,濃縮與減壓蒸餾得到(80.3克,84%),沸點62 °C ( 0.82 mmHg) , NMR (CDC13> 200 MHz) ^ 7.33 (S, 1H), 4.08 (q, J = 7.2 Hz, 2HX 2.56 (q, J = 7.4Hz, 2H), 1.73 (S, 3H), 1.36 (t, J = 7.2 Hz, 3H), 1.13 (t, J = 7.4Hz, 3H) » 3,5 -二甲基-4-¥唏-2-羧酸與3 ,5 -二甲基-4-哌哜-2-乙 基羧酸酯 - 將2 -曱基-1 -戊埽-1 -乙氧基-3 -酮(4.05克,0.028莫耳)與二 乙基草酸酯(4.1克,0.028莫耳)的混合液滴入迴流狀態的50毫 升0.626M乙醇溶液中,費時約0.5小時。然後繼續迴流加熱 0.5小時。將所得之紅色溶液濃縮並倒入碎冰中,以三氧甲 烷萃取二次,合併之有機液再以水洗一次。洗液與水層合 併並以6N HC1調至酸性後即有沈澱析出,過濾收集並眞空 乾燥之得到3,5-二甲基-4-哌哜-2-羧酸(0.94克,20%),其 爲白色粉末,熔點185胃187°C ( 3 : 1乙酸乙酯/苯),Ή NMR (DMSO - d6),8.19 (S,1Η),2.15 (S,3Η),1.83 (S, 3H)rMs (13 ev) m / z-(%) j 168.0 (M+, 100), 124.1 (20),95.0 (20)。有機層經減壓濃縮,殘留>物 以正己烷及乙醚之Λ昆合液稀釋並冷至0 4c即有沈澱析出, r 過濾收集並眞空乾燥之得到3,5 -二甲基-4-哌哜-2-乙基羧 酸酯(2.28克,40% ),其爲白色粉末,熔點81 - 83°C ( 1 : 4乙酸 乙酯 / 正己烷),屯 NMR (CDC13),7.73 (S,1H),4.42 (q,J = 7.2 Hz, 2H), 2.31 (S, 3H), 1.96 (S, 3H), 1.42 (t, J = 7.2 Hz, 3H), Ms (13 ev) m / z (%): 1%·1 (M+,45),167.1 (100)。 45d99.DOC - 9 3 -* ----------- (請先閱讀背面之注意事項再,填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 434205 A7 B7 五、發明説明(21) g,5 -二甲基-4 -哌哜-2 -羧酸經酯化生成3 , 5 -二甲基-4 ·喩 脅~-2 -乙基截酸醋 將3,5 -二甲基-4 -哌哜-2 -羧酸(3克,17.85毫莫耳)溶於無 水乙醇(30毫升),然後滴入濃硫酸〇.5克,將此混合物迴流 加熱5小時後作減壓濃縮,殘留液以三氣甲烷稀釋並然後 以水洗及10%碳酸氫鈉水溶液洗,有機液經乾燥濃縮得到 3,5 -二甲基-4 -哌·,弄,2 -乙基羧酸酯。 2 -羧醯胺-3, 二甲基-4-吡酮 於高壓釜中,加入3,5 -二曱基-4-哌噚-2-乙基羧酸酯 (10.2克,52.0毫莫耳)與180毫升之飽和乙醇胺溶液並置於油 浴鍋上,然後在密閉的情況下加熱並攪拌48小時,其中油 浴鍋的溫度保持120°C。所得溶液經放冷後有大量白色固體 析出,過濾收集並眞空乾燥之得標的化合物6.2克,濾液經 減壓農縮,殘留物以少董乙醚碾製過濾並眞空乾燥之又得 標的化合物1.7克,合併二次之產量是7.9克(91%) »其爲白 色粉末,熔點大於 300°C,NMR (6d - DMSO),8.02 (brs,1H), 7.85 (brs, 1H), 7.59 (S, 1H), 2.01 (S, 3H), 1.91 (S, 3H>rMs (m / e, rel intensityX 166.1 (100),149.1 (50),121.0 (70)。 、 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再一填寫本頁) 2 -羧醯胺-5 -二f基-4 -甲氧基吡啶 於500毫4丙酮中,依次加入2 -羧醯胺-3,5 -二甲基- 4-吡酮(16.6克,0_1莫耳),二甲基硫酸(8克,0.063莫耳)與無水碳 酸鉀(41.4克,0.3莫耳),然後迴流加熱5小時,所得溶液放冷 後過濾並以丙酮洗,將濾液作減壓濃縮,殘留物以水稀釋 ,過濾並眞空乾燥之得標的化合物(16.2克,90%)。其爲白色 . DOC — 2 4 *" 本紙張尺度適用中國國家橾準(CNS ) A4規;^ ( 2】〇X 297公釐) ~ 4342 A7 B7 五、發明説明(22 經濟部中央標準局員工消费合作社印製 粉末,熔點 127 - 129°C,旧 NMR (CDC13, 200 MHz),8.20 (s,1H),7.83 (sb, 1H), 5.56 (brs, 1H), 3.78 (S, 3H), 2.64 (S, 3H), 2.31 (S, 3H), Ms (m / e, rel intensity), 180.1 (M+,100),163,1 (100), 135.1 (75),105.1 (60)。 2 -腈-3,5 -二甲基-4 甲氧基吡啶 於冰冷的二氯甲烷(80毫升)中依次加入2,3,5 -三曱基· 4 -甲氧基吡啶(3.3克,18.3毫莫耳)與吡啶(1.6克,20.25毫莫耳) ,然後慢慢滴入i氟醋酸酐(8.5克,38_6毫莫耳),然後在〇 I 下攪拌1小時a及在室溫下攪拌隔夜》所得溶液先後經水 洗,1 0 %碳酸鉀水溶液洗與水洗,有機層經乾燥,濃縮得 標的化合物(2:7克,91%),熔點 56 - 60°C,NMR (CDC13, 200 MHz), 8.33 (S, 3H), 3.85 (S, 3H), 2.48 (S, 3H), 2.34 (S, 3H), Ms (m / e, rel intensity),162_0 (100),H7.l (8〇)。其中所有的分析數據都與德國 專利(DE 384〇372 ( 1988 ))所報告者完全吻合,然而採取之合 成策略截然不同。 2 -胺甲基-3,5 -二甲某-4-甲氧基吡啶 將2 -腈-3,5-二甲基-4-甲氧基吡啶(5克,30.86毫莫耳)溶 於160毫升飽和甲醇胺中並加入5克雷足‘(Raney Nicket),、 接著通入氫氣並保持一定壓力下攪拌3天,將所得溶液應 由Celite過濾',並濃^濾液得到粗製品,將粗製品以KtigeJl〇hr 裝置作眞空蒸餾得標的化合物(3.6克,70% ),中NMR (CDC13, 200 MHz), 8.20 (S, 1H), 3.90 (S, 2H), 3.75 (S, 3H), 2.24 (S, 3H), 2.21 (S, 3H), 1.94(brS,2H)。 2 -羥甲基-3,5 -二甲基-4-甲氧基吡啶 於43毫升1〇〇/。冰醋酸水溶液加入2 _胺甲基_ 3,5 -二甲基- 請 先 閲 讀 背 面 意 事 項 再 II 寫 本 1 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 43421 A7 B7 五、發明説明(23 ) 4 -甲氧基吡啶(2.5克,15.06毫莫耳)並在冰浴下冷至,接 著加入含亞硝酸鈉(3.1克,44.92毫莫耳)溶於水(η毫升)的水 溶液並保持在0 °C攪拌1小時。然後加入26毫升4Ν NaOH與 50毫升三氣甲烷,有機層分出後再以5〇毫升三氣甲烷萃取 水層,合併之有機層經水洗,乾燥與濃縮得到2 -羥基-3,5 -二甲基-4 -甲氧基吡啶(2.2克,88% ),其Ή NMR及其他 分析數據都與標举品吻合。依本身已知方法將此化合物與 亞硫醯氣(80(¾ )作用並經中和得到2 -氣甲基· 3 , 5 —二甲 基-4-曱氧基p比咬。 爲便於説明本發明,已將本發明之較佳實施例例述於上 文中,但並不以此侷限本發明之範圍。凡熟悉本技藝人仕 得任施匠思而爲諸般修飾,然皆不脱如附申請專利範圍所 欲保護者。 I mV flm 1^1 ^^^^1 Γ ., (請先閱讀背面之注意事項再一填寫本頁) 經濟部中央標準局員工消費合作杜印策 本紙張尺度適用中國國家標隼(CNS ) A4規格(210X297公釐), DOC This paper uses Chinese National Standards (CNS) A4 specifications {21 ο X 297 mm) 434206 A7 B7 Reprinted by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the invention (20) The filtrate was concentrated and diluted with water. The diluted solution was extracted twice with ethyl acetate. The organic layer was washed with dilute potassium carbonate aqueous solution and washed with water, then dried, concentrated and distilled under reduced pressure to obtain (80.3 g, 84%). Boiling point 62 ° C (0.82 mmHg), NMR (CDC13> 200 MHz) ^ 7.33 (S, 1H), 4.08 (q, J = 7.2 Hz, 2HX 2.56 (q, J = 7.4Hz, 2H), 1.73 (S, 3H), 1.36 (t, J = 7.2 Hz, 3H), 1.13 (t, J = 7.4Hz, 3H) »3,5-dimethyl-4- ¥ 唏 -2-carboxylic acid and 3,5-di Methyl-4-piperazine-2-ethylcarboxylic acid ester-2-Methenyl-1 -pentamidine-1 -ethoxy-3 -one (4.05 g, 0.028 mole) with diethyloxalic acid The mixed solution of the ester (4.1 g, 0.028 mol) was dropped into 50 ml of 0.626 M ethanol solution under reflux, which took about 0.5 hours. Then continued heating under reflux for 0.5 hours. The resulting red solution was concentrated and poured into crushed ice. Extracted twice with trioxane, combined The solution was washed with water again. The washing solution was combined with the aqueous layer and adjusted to acidity with 6N HC1, and then a precipitate precipitated out. The 3,5-dimethyl-4-piperazine-2-carboxylic acid (3,5-dimethyl-4-piperazine-2-carboxylic acid ( 0.94 g, 20%), which is a white powder, melting point 185 stomach 187 ° C (3: 1 ethyl acetate / benzene), Ή NMR (DMSO-d6), 8.19 (S, 1Η), 2.15 (S, 3Η) , 1.83 (S, 3H) rMs (13 ev) m / z-(%) j 168.0 (M +, 100), 124.1 (20), 95.0 (20). The organic layer was concentrated under reduced pressure, and the residue > The Λ-Kun mixture of alkane and diethyl ether was diluted and cooled to 0 4c, and then a precipitate was precipitated. R was collected by filtration and air-dried to obtain 3,5-dimethyl-4-piperazine-2-ethylcarboxylic acid ester (2.28 g , 40%), which is a white powder, melting point 81-83 ° C (1: 4 ethyl acetate / n-hexane), NMR (CDC13), 7.73 (S, 1H), 4.42 (q, J = 7.2 Hz, 2H), 2.31 (S, 3H), 1.96 (S, 3H), 1.42 (t, J = 7.2 Hz, 3H), Ms (13 ev) m / z (%): 1% · 1 (M +, 45) , 167.1 (100). 45d99.DOC-9 3-* ----------- (Please read the notes on the back before filling in this page) The size of the paper is applicable to China National Standard (CNS) A4 (210X 297) (%) 434205 A7 B7 V. Description of the invention (21) g, 5-dimethyl-4-piperazine-2-carboxylic acid is esterified to 3, 5 -dimethyl-4 Glyoxylic acid was dissolved in 3,5-dimethyl-4-piperidin-2-carboxylic acid (3 g, 17.85 mmol) in anhydrous ethanol (30 ml), and then 0.5 g of concentrated sulfuric acid was added dropwise. The mixture was heated under reflux for 5 hours and then concentrated under reduced pressure. The residual solution was diluted with three gas methane and then washed with water and 10% sodium bicarbonate aqueous solution. The organic solution was concentrated by drying to obtain 3,5-dimethyl-4 -piper ·, Allyl 2-ethylcarboxylate. 2-Carboxamidamine-3, dimethyl-4-pyridone In an autoclave, add 3,5-difluorenyl-4-piperazine-2-ethylcarboxylic acid ester (10.2 g, 52.0 mmol) ) And 180 ml of a saturated ethanolamine solution and placed on an oil bath, and then heated and stirred for 48 hours in a closed condition, wherein the temperature of the oil bath is maintained at 120 ° C. After the solution was allowed to cool, a large amount of white solids precipitated, collected by filtration and air-dried to obtain 6.2 g of the target compound, and the filtrate was reduced under reduced pressure. The residue was milled and filtered with ether, and 1.7 g of the target compound was air-dried. The combined secondary yield is 7.9 g (91%) »It is a white powder with a melting point greater than 300 ° C, NMR (6d-DMSO), 8.02 (brs, 1H), 7.85 (brs, 1H), 7.59 (S, 1H), 2.01 (S, 3H), 1.91 (S, 3H> rMs (m / e, rel intensityX 166.1 (100), 149.1 (50), 121.0 (70). Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (Please read the precautions on the back and fill in this page again.) 2 -Carboxamidine-5 -difyl-4 -methoxypyridine in 500 mmol of 4 acetone, and then add 2-carboxamide-3,5 -Dimethyl-4-pyrone (16.6 g, 0_1 mole), dimethyl sulfate (8 g, 0.063 mole) and anhydrous potassium carbonate (41.4 g, 0.3 mole), and then heated under reflux for 5 hours to obtain After the solution was allowed to cool, it was filtered and washed with acetone. The filtrate was concentrated under reduced pressure, the residue was diluted with water, filtered and air-dried to obtain the target compound (16.2 g, 90%). White. DOC — 2 4 * " This paper size applies to China National Standards (CNS) A4 regulations; ^ (2] 〇X 297 mm) ~ 4342 A7 B7 V. Description of invention (22 Staff Consumption of Central Standards Bureau, Ministry of Economic Affairs Cooperative printed powder, melting point 127-129 ° C, old NMR (CDC13, 200 MHz), 8.20 (s, 1H), 7.83 (sb, 1H), 5.56 (brs, 1H), 3.78 (S, 3H), 2.64 (S, 3H), 2.31 (S, 3H), Ms (m / e, rel intensity), 180.1 (M +, 100), 163, 1 (100), 135.1 (75), 105.1 (60). 2-Nitrile -3,5-Dimethyl-4 methoxypyridine in ice-cold dichloromethane (80 ml) was added with 2,3,5-trimethylpyridinyl 4-methoxypyridine (3.3 g, 18.3 mmol) in this order. Ear) with pyridine (1.6 g, 20.25 mmol), then slowly drop in i fluoroacetic anhydride (8.5 g, 38-6 mmol), and then stir at 0 ° C for 1 hour and overnight at room temperature. " The resulting solution was washed with water, 10% potassium carbonate aqueous solution and water. The organic layer was dried and concentrated to obtain the target compound (2: 7 g, 91%), melting point 56-60 ° C, NMR (CDC13, 200 MHz), 8.33 (S, 3H), 3.85 (S, 3H), 2.48 (S, 3H), 2.34 (S, 3H), Ms (m / e, re l intensity), 162_0 (100), H7.1 (80). All of the analysis data are in complete agreement with those reported by the German patent (DE 3840372 (1988)), but the synthetic strategy adopted is quite different. 2-Aminomethyl-3,5-dimethyl-4-methoxypyridine Dissolve 2-nitrile-3,5-dimethyl-4-methoxypyridine (5 g, 30.86 mmol) 160 ml of saturated methanol amine was added to 5 grams of Raney Nicket, followed by hydrogen and stirring for 3 days under a certain pressure. The resulting solution should be filtered through Celite, and the filtrate was concentrated to obtain a crude product. The crude product was subjected to vacuum distillation using a KtigeJ10hr device to obtain the target compound (3.6 g, 70%), medium NMR (CDC13, 200 MHz), 8.20 (S, 1H), 3.90 (S, 2H), 3.75 (S, 3H) , 2.24 (S, 3H), 2.21 (S, 3H), 1.94 (brS, 2H). 2-hydroxymethyl-3,5-dimethyl-4-methoxypyridine in 43 ml of 100 /. Add 2 _ amine methyl _ 3,5-dimethyl-glacial acetic acid aqueous solution-Please read the notes on the back before writing II. 1 This paper size applies to Chinese National Standard (CNS) A4 (210X 297 mm) 43421 A7 B7 5 2. Description of the invention (23) 4-methoxypyridine (2.5 g, 15.06 mmol) and cooling to an ice bath, then adding sodium nitrite (3.1 g, 44.92 mmol) to water (η ml) ) And hold it at 0 ° C for 1 hour. Then, 26 ml of 4N NaOH and 50 ml of trigasmethane were added. After the organic layer was separated, the aqueous layer was extracted with 50 ml of trigasmethane. The combined organic layers were washed with water, dried and concentrated to obtain 2-hydroxy-3,5--2 Methyl-4-methoxypyridine (2.2 g, 88%). Its NMR and other analytical data were in good agreement with the standard product. According to a method known per se, this compound is reacted with thionine gas (80 (¾) and neutralized to obtain a 2-gas methyl · 3,5-dimethyl-4-fluorenyloxy p specific bite. For the convenience of explanation In the present invention, the preferred embodiments of the present invention have been described above, but it is not intended to limit the scope of the present invention. Anyone who is familiar with the art and who is capable of making artisans can modify it in any way. Attach those who want to protect the scope of the patent application. I mV flm 1 ^ 1 ^^^^ 1 Γ., (Please read the precautions on the back and fill in this page) Standards apply to China National Standard (CNS) A4 (210X297 mm)

Claims (1)

434206434206 六、申請專利範圍 1. 一種製備式1 a化合物及其衍生物之方法 R3 .R4Scope of patent application 1. A method for preparing compounds of formula 1 a and derivatives thereof R3. R4 一, la — C〇 ' (其中,R1、R2及114爲(:1-(:4烷基,且R3及R5爲氫或自素) ,此方法包括,: (1)以下式化合物爲起始物 *·* r2、^co2c2h5 0 <jO 與式BCH2NH2 (其中B爲苯基或經取代之苯基)進行脱 水反應生成下式保護態的晞胺酯 _ " ,co2c2h5 ΝΗ ch2b ⑵將⑴得到之保護態烯胺酯與可供應烷醯陽離子之試 劑進行it醯化反應生成下式烷醯化烯胺酯衍生物' - I ml ^in Ι^ϋ · ml ml 、一-3J (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 CO,Et1, la — C0 ′ (wherein R1, R2, and 114 are (: 1-(: 4 alkyl, and R3 and R5 are hydrogen or autogen)), this method includes: (1) a compound of the formula The starting material * · * r2, ^ co2c2h5 0 < jO and BCH2NH2 (where B is phenyl or substituted phenyl) are dehydrated to form a sulfonium ester in the protected state of the formula: ", co2c2h5 ΝΗ ch2b ⑴The obtained protected enamine ester is reacted with a reagent capable of supplying alkyl cations to perform an alkylation reaction to form an alkylated enamine ester derivative of the formula '-I ml ^ in Ι ^ ϋ · ml ml 、 1-3J (Please (Please read the notes on the back before filling out this page) CO, Et printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs CH2B cU ⑶將⑵得到之規•醯化烯胺酯衍生物經強檢處理後加熱 進行分子内環化生成下式峨_衍生物 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) A8 B8 C8 D8CH2B cU (3) The rules obtained from ⑵ • The fluorenated enamine ester derivative is heated to undergo molecular cyclization after heating to generate the following formula _ derivative Mm) A8 B8 C8 D8 ^34206 六、申請專利範圍 OH^ 34206 6. Scope of patent application OH CH2B 〆 ⑷將⑶得到之p比酮衍生物先規基化再加以氫化而分別 得下式化合物 OR31 OR31 ,R3 氪化 (其中R31爲C,-C4烷基) ^ ⑸將⑷得到之氫化產物與磷醯卣化物反應,生成下式 經鹵素取代之吡啶衍生物(式la,其中R1、R2及R4爲 Q - Q烷基且R3及y爲闺素) X n In— HI 1^1 I 1^1 I nn 11 n i ^^^1--SJ {請先閱讀背面之注意事項再填寫本頁} 卫4CH2B 规 The p obtained from ⑶ is first regularized and then hydrogenated to obtain compounds of the formula OR31 OR31 and R3 respectively (where R31 is a C, -C4 alkyl group) ^ 氢化 The hydrogenated product obtained from ⑷ Reacts with a phosphine compound to form a halogen-substituted pyridine derivative of the following formula (formula la, wherein R1, R2, and R4 are Q-Q alkyl groups and R3 and y are bovines) X n In— HI 1 ^ 1 I 1 ^ 1 I nn 11 ni ^^^ 1--SJ {Please read the precautions on the back before filling this page} 卫 4 經濟部中央揉隼局員工消費合作社印裝 (其中X爲鹵素);及 > ⑹視情丸將⑸得到之經齒素取代之I»比咬衍生物進行氯 解除去南素原子得下式吡啶化合物(式la,其中R1、 R2及R4爲q - C4烷基且R3及R4爲氫)Printed by the Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs (where X is halogen); > ⑹Shiqing Pills will be chlorinated by dentition-derived I »biten derivatives obtained by 南 to remove the sulfonium atom to obtain the following formula: Pyridine compounds (formula la, where R1, R2, and R4 are q-C4 alkyl and R3 and R4 are hydrogen) ,R4 -28 本紙張尺度適用中國國家標準(CNS) A4規格(210x297公釐) 434206 六、申請專利範圍 A8 B8 C8 D8 根據申4專利範圍第!項之方法,其中步驟⑴中 經濟部中央樣嗥局員工消費合作社印裳 爲爷基胺。 3·根據申請專利範圍第1項之方法 陽離子之試劑爲丙醯氣或丙酸酐 下於40-60 °C中進行。 也根據申請專利辱圍第3項之方法 二級胺或環氧丙燒。 次根據申請專利範圍第1項之方法 氫化納、特丁醇鉀或胺化鈉。 6-根據申請專利範圍第1项之方法 化係以二烷基硫酸於11〇_ 13(rc下進行 7·根據申請專利範園第!項之方 .^ „ 再笮步驟⑸中之磷醯 卣化物爲鱗酿氣及伽漠,且其係於11〇_職下進行。 8· 2中請專利範圍第1項之方法,其中步_係於脱酸 劑存在下進行。 9·根據申請專利範園第8項之方法, 乙醇。 1 ΐ脱蛟.劑爲氨水或 10·根據申請專利範圍第1項之方法, 、 / 丹中式la化合物鳴 2,3,5 -三甲基吡啶。 r 让—種製備式lb化合物及其衍生物之方法,其包括 其中步驟⑵中之烷醯 且其係於脱酸劑存在 其中脱酸劑爲'^比症、 其中步驟⑶之強鹼爲 其中步驟⑷中之烷基 ---------,表----^----iT------疒, (請先閲讀背面之注意事項再填寫本頁), R4 -28 This paper size is applicable to Chinese National Standard (CNS) A4 specification (210x297 mm) 434206 6. Scope of patent application A8 B8 C8 D8 According to the scope of patent application No. 4! The method of the above item, in which the step Yinzhong of the Central Consumers' Bureau of the Ministry of Economic Affairs of the Consumer Cooperatives Co., Ltd. is ceylamine. 3. The method according to item 1 of the scope of patent application. The cation reagent is propane gas or propionic anhydride at 40-60 ° C. Also according to the method of applying for a stigma on the third item, secondary amine or propylene oxide. The method according to item 1 of the scope of patent application is sodium hydride, potassium t-butoxide or sodium amine. 6- The method according to item 1 of the scope of the patent application is carried out with dialkyl sulfuric acid at 11-13 (rc. 7 according to the method of the patent application in the park! Item ^ 笮 笮 the phosphorus in the step 醯The tritium compounds are scale fermentation gas and gamma desert, and they are carried out under the 11__. 8. 2 method of the scope of patent application, wherein step _ is performed in the presence of a deacidifying agent. 9. According to the application The method of the patent No. 8 item is ethanol. 1 The desulfurization agent is ammonia or 10. According to the method of the item No. 1 of the scope of the patent application, the compound of the formula la in China is called 2,3,5-trimethylpyridine. r Let a method for preparing a compound of formula lb and derivatives thereof, which comprises the alkane in step ⑵ and it is in the presence of a deacidifying agent where the deacidifying agent is ^ Bi Zheng, where the strong base of step ⑶ is among them Alkyl in step ------------, table ---- ^ ---- iT ------ 疒, (Please read the precautions on the back before filling this page) N, \R5 C> 45399.DOC -29 本紙張尺度適用中國國家標準(CNS ) A4洗格(210X297公釐) 434206 A8 B8 C8 D8 申請專利範圍 (其中’ R1、R2及R4爲C| _ Q _烷基;R3爲〇R3l,其中r31 爲C1 - C4 -烷基;且R5爲氫、羥基及op (〇) (〇R”)2,其中 R51爲甲基或乙基) ⑴將下式吡酮化合物經氫化及以Hal P( 0 ) ( OR51 )2 (其中 Hal爲_素,且rsi爲甲基或乙基)進行畴酷化反應後 ’分別得到產物經基p比症衍生物及碑酿衍生物 PR31 OR31 OR31N, \ R5 C > 45399.DOC -29 This paper size is applicable to Chinese National Standard (CNS) A4 wash case (210X297 mm) 434206 A8 B8 C8 D8 Patent application scope (where 'R1, R2 and R4 are C | _ Q -Alkyl; R3 is OR3l, where r31 is C1-C4-alkyl; and R5 is hydrogen, hydroxyl and op (〇) (〇R ") 2, where R51 is methyl or ethyl) ⑴ will be the following formula The pyridone compound is hydrogenated and subjected to a domain quenching reaction with Hal P (0) (OR51) 2 (where Hal is _ prime and rsi is methyl or ethyl) to obtain the product via a radical derivative and Stele derivative PR31 OR31 OR31 生物(式lb,其中Ri、R2及R4爲Q - C4 烷基;R3爲 〇R31 ’其中R31爲C, - C4 -烷基;且R5爲氫)Biological (Formula lb, wherein Ri, R2 and R4 are Q-C4 alkyl; R3 is 〇R31 ′ where R31 is C,-C4-alkyl; and R5 is hydrogen) (請先鬩讀背面之注意事項再填寫本頁) 經濟部中央梯準局員工消費合作社印製 12. 根據申請專利範圍第1 1項之方法u其中步驟⑵係,以選«C 、 自包括鋰、鈉、鉀或鈦之金屬於液氨中進行還原反應β \ 13. 根據申請專利範園第1 1項之方法,其中步驟⑵係於質 子供给試劑存在下進行。 14. 根據申請專利範圍第1 3項之方法,其中之質子供給試 劑爲第三丁醇。 15. 根據申請專利範圍第! !項之方法,其中式〗b化合物爲 2,3, 5-三甲基_4_甲氧基吡啶。 -30 - 45899.DOC 本紙張尺度逋用中國國家標準(CNS )八4規>格(21〇X297公釐) 434206 A8 B8 C8 D8(Please read the precautions on the back before filling out this page) Printed by the Consumer Cooperatives of the Central Government Bureau of the Ministry of Economic Affairs 12. According to the method of item 11 of the scope of patent application, where the steps are not selected, «C, self-included Reduction reaction of lithium, sodium, potassium or titanium metal in liquid ammonia β 13. The method according to item 11 of the patent application park, wherein step ⑵ is performed in the presence of a proton donating reagent. 14. The method according to item 13 of the scope of patent application, wherein the proton donating reagent is tertiary butanol. 15. According to the scope of patent application! !! Item 2, wherein the compound of formula (b) is 2,3,5-trimethyl-4-methoxypyridine. -30-45899.DOC This paper uses the Chinese National Standard (CNS) Rule 8 > Standard (21 × 297 mm) 434206 A8 B8 C8 D8 六、申請專利範圍 16.根據申請專利範圍第i 1項之方法, 氫進行氧化反應以生成吡啶氧化物 17. —種製備式I c化合物及其衍生物之方法 其進一步以過氧化6. Scope of patent application 16. According to the method of item i 1 of the scope of patent application, hydrogen is oxidized to form pyridine oxide. 17. A method for preparing the compound of formula I c and its derivatives, which is further peroxidized. Ic Ύ (其中,R、R2及R4爲Ci _ Q _烷基;r3爲〇把 其中R31爲C, - C:4 -烷基;且r5爲鹵素) 其包括將下式,比明化合物與由化試劑反應’得到 產物與双由化產物的混合物 OR31 OR31'R4 R2、丄.r4 +Ic Ύ (wherein R, R2, and R4 are Ci_Q_alkyl; r3 is 0; wherein R31 is C, -C: 4-alkyl; and r5 is halogen), which includes the following formula: The reaction of the chemical reagent 'to obtain a mixture of the product and the dual chemical product OR31 OR31' R4 R2, 丄 .r4 + 或鹵素, 單鹵化Or halogen, monohalogenated X i i fl m u n » - « - I ^ n I u. I Γ (請先閎讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印策 (其中X爲鹵素)。 is_根據申請專利範圍第17項之方法,其中反應係於室溫 至l〇(TC下進行,且其中之齒化試劑s氣化試劑。 、 19.根據中請專利气圍第18項之方法,其中反應係於6㈣。 下進存,且其中之氣化試劑爲ρ〇α3,s〇Q2,rr"_ p(〇)ci(其中r,與R,,分別爲烷基或苯基)。 2α根據申請專利範圍第1?項之方法’其中民,、R2及Μ爲 甲基’ R3爲甲氧基且R5爲氣。 21. —種製備式I d化合物之方法, 本紙張尺度適用肀國國家標準(CNS ) M规格(210X297公* ) 、申請專利範圍 3 888 ABCDX i i fl m u n »-«-I ^ n I u. I Γ (Please read the precautions on the back before filling out this page) The policy of employee consumer cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (where X is halogen). is_ The method according to item 17 of the scope of patent application, wherein the reaction is carried out at room temperature to 10 ° C., and the toothing reagent s gasification reagent therein. 19. According to the patent application No. 18 Method, where the reaction is at 6 ° C, and the gasification reagent is ρ〇α3, soQ2, rr " _ p (〇) ci (where r, and R, are alkyl or phenyl, respectively ). 2α The method according to item 1 of the scope of the patent application 'wherein, R2, and M are methyl' R3 is methoxy and R5 is gas. 21. —A method for preparing a compound of formula I d, this paper scale Applicable National Standard (CNS) M specification (210X297 male *), patent application scope 3 888 ABCD 二中,R爲鹵甲基’胺曱基,羥甲基’腈基或羰胺基;R2 及 r^Ci_c4燒基;R4〇R31(其中 r3i 爲 CA·坑基) ;且R5爲氫,亭包括: ⑴將下式起始物 r* 0In two, R is a halomethyl'amino group, a hydroxymethyl'nitrile group or a carbonylamino group; R2 and r ^ Ci_c4 alkyl; R4OR31 (where r3i is CA · pit group); and R5 is hydrogen, The kiosk includes: ⑴ will start the following formula r * 0 ,R4 〇H W 與自烷化物R6X(其中圮爲Ci_C4_烷基且χ爲画素)在 鹼性下進行氧烷化作用而得到下式化合物;R4 0H W and alkylate R6X (where 圮 is Ci_C4_ alkyl and χ is a pixel) are subjected to oxyalkylation under basic conditions to obtain compounds of the following formula; (請先閲讀背面之注意事項再填寫本頁) 經濟部中央橾準局貝工消費合作.杜印製 ⑵接著將⑴之產物與二乙基草酸雯在鹼性下進行瞌化 且同時合環分別生歲哌η弄酸與哌噚酯 、 Ο *,R4 ho2c(Please read the notes on the back before filling out this page) The cooperation between shellfish and consumer goods of the Central Bureau of Standards of the Ministry of Economic Affairs. Raw piperidine η acid and piperidine ester, 〇 *, R4 ho2c 及 ro2cAnd ro2c ⑶將⑵所得之哌哞酯於高壓釜中加熱進行胺化並同時 酿胺化得到下式吡酮醯胺衍生物 -32 本紙張Hi财關家標率⑺0 X 297公着 4342 06 A8 BS C8 D8 六、申請專利範圍(3) The piperidine ester obtained by heating is heated in an autoclave for amination and simultaneous amination to obtain the pyridoxamine amine derivative of the following formula -32 paper Hi-Fi family standard rate 0 0 297 public 4342 06 A8 BS C8 D8 six Scope of patent application 酬0)<r、N/ H 01¾ 請 先 閲 ⑷將⑶所得之吡酮醯胺衍生物於鹼性下烷基化生成坑 基化產物 之 注 OR31(Remuneration 0) < r, N / H 01¾ Please read ⑷The alkylation of the pyridonepyridine amine derivative obtained from ⑶ under basic conditions to form pits. Note OR31 I ⑸將⑷之烷基化產物以脱水劑處理得到下式腈衍生物 (其中 R2、R4 及 1^31爲(:1-(:4-烷基) OR31 ,R4 ⑹視情況將(5 )之腈衍生物經觸媒僂化還原得到下#甲 胺化合物 OR31 ' ,R4 ⑺視情況將(6 )之甲胺化合物經重氮化與鹼性水解得到 下式羥甲基吡啶化合物 本紙法尺度逍用中國囷家梯準(CNS >A4規格(210X297公釐) 訂I ⑸ treatment of the alkylated product of ⑷ with a dehydrating agent to obtain a nitrile derivative of the formula (where R2, R4 and 1 ^ 31 are (: 1-(: 4-alkyl) OR31, R4, depending on the situation, (5) The nitrile derivative is reduced by catalytic reduction to obtain the following #methylamine compound OR31 ', R4. Depending on the case, the methylamine compound of (6) is subjected to diazotization and alkaline hydrolysis to obtain the methylol pyridine compound of the following formula. Easy to use Chinese family ladder standard (CNS > A4 size (210X297 mm)) 經濟部中央標隼局員工消费合作社印製Printed by the Staff Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs 434206 A8 B8 C8 D8 六、申請專利靶圍 OR31434206 A8 B8 C8 D8 VI. Patent application target range OR31 ⑻視情況將(7 )之產物鹵化得到下式化合物Depending on the case, the product of (7) is halogenated to give the compound of the following formula 經濟部中央標準局員工消費合作社印製 (其中X爲鹵素)。 22. 根據申請專利範圍第2 1項之方法,其中步驟⑴中之鹵 烷化物爲溴乙烷。 23. 根據申請專利範圍第2 1項之方法,其中步骤⑵中之驗 性化合物爲乙醇鈉、特丁醇鉀或胺化鈉。 24根據申請專利範圍第? 1項之方法,其中步驟⑷中之烷 基化反應係以二規》基硫酸並於k2co3/丙_存在下進行。 25.根據申請專利範圍第2 1.項之方法,其中步驟⑸之脱水 劑係選自三氟醋酸酐與吡啶之混合試劑、五氧化二磷、 骑醯氣、五氣化鱗、二甲基甲醯胺/酸、二甲基甲醯胺* 二甲縮醛及亞見酿氣。 1 26·根據申請專利範園第2 5項之方法 氟醋酸酐與吡啶之混合試劑。 27·根據申請專利範圍第2 1項之方法 3,5·二甲基-4-甲氧基-吡啶-2-骑 2叹根據申請專利範圍第2 1項之方法 其中該脱水劑爲三 其中式Id化合物爲 其中式Id化合物爲 (請先閲讀背面之注意事項再填寫本頁) 34 €34206 Μ C8 D8 六、申請專利範圍 2 -羥甲基-3,5 -二甲基-4-甲氧基吡啶。 29.根據申請專利範圍第2 1項之方法,其中式I d化合物爲 2 -氣甲基-3 ,5 -二甲基-4-甲氧基吡啶。 經濟部中央標準局員工消費合作社印褽Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (where X is halogen). 22. The method according to item 21 of the scope of patent application, wherein the haloalkane in step (i) is bromoethane. 23. The method according to item 21 of the scope of patent application, wherein the test compound in step (2) is sodium ethoxide, potassium t-butoxide or sodium aminate. 24th according to the scope of patent application? The method according to item 1, wherein the alkylation reaction in step (i) is carried out with dibasic sulfuric acid in the presence of k2co3 / propane. 25. The method according to item 21 of the scope of patent application, wherein the dehydrating agent in step ⑸ is selected from the mixed reagent of trifluoroacetic anhydride and pyridine, phosphorus pentoxide, riding gas, pentagasine scale, dimethyl Formamidine / acid, dimethylformamide * dimethyl acetal and Ami Gas. 1 26. The method according to item 25 of the patent application park. Mixed reagent of fluoroacetic anhydride and pyridine. 27. Method according to item 21 of the scope of patent application 3,5 · Dimethyl-4-methoxy-pyridine-2-cycline 2 Method according to item 21 of the scope of patent application wherein the dehydrating agent is three of which The compound of formula Id is in which the compound of formula Id is (please read the notes on the back before filling in this page) 34 € 34206 Μ C8 D8 VI. Application for patent scope 2-hydroxymethyl-3,5-dimethyl-4-methyl Oxypyridine. 29. The method according to item 21 of the patent application, wherein the compound of formula Id is 2-aminomethyl-3,5-dimethyl-4-methoxypyridine. Employees' Cooperatives, Central Standards Bureau, Ministry of Economic Affairs, India (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家棟準(CNS ) A4規格(210X297公釐)(Please read the precautions on the back before filling this page) This paper size is applicable to China National Standard (CNS) A4 (210X297 mm)
TW86104131A 1997-04-01 1997-04-01 Methods for the preparation of pyridine derivatives for preparing an antisecretory compound, omeprazole TW434206B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW86104131A TW434206B (en) 1997-04-01 1997-04-01 Methods for the preparation of pyridine derivatives for preparing an antisecretory compound, omeprazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW86104131A TW434206B (en) 1997-04-01 1997-04-01 Methods for the preparation of pyridine derivatives for preparing an antisecretory compound, omeprazole

Publications (1)

Publication Number Publication Date
TW434206B true TW434206B (en) 2001-05-16

Family

ID=21626498

Family Applications (1)

Application Number Title Priority Date Filing Date
TW86104131A TW434206B (en) 1997-04-01 1997-04-01 Methods for the preparation of pyridine derivatives for preparing an antisecretory compound, omeprazole

Country Status (1)

Country Link
TW (1) TW434206B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110317164A (en) * 2019-07-06 2019-10-11 抚州三和医药化工有限公司 A kind of preparation method of intermediate of omeprazole

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110317164A (en) * 2019-07-06 2019-10-11 抚州三和医药化工有限公司 A kind of preparation method of intermediate of omeprazole
CN110317164B (en) * 2019-07-06 2022-08-19 抚州三和医药化工有限公司 Preparation method of omeprazole intermediate

Similar Documents

Publication Publication Date Title
TW518329B (en) Process for preparing derivatives of the taxoid family
ES2353640T3 (en) PROCEDURE FOR THE PREPARATION OF TELMISARTAN.
EP2687510A1 (en) Method for preparing 2,3-dichloropyridine
DK163505B (en) METHOD OF PREPARING MONO AND DISUBSTITUTED PYRIDINE CARBOXYLATES
JP4866610B2 (en) Pyridyltetrahydropyridines and pyridylpiperidines
TW201029975A (en) Process for manufacturing substituted 3-pyridylmethyl ammonium bromides
Zhang et al. Ullmann-type C–N coupling reaction catalyzed by CuI/metformin
TW201021702A (en) 2-[(1-cyanopropyl)carbamoyl]-5-methoxymethyl nicotinic acids and the use thereof in manufacturing herbicidal imidazolinones
CN101016293A (en) Preparing method of imatinib
CA3126738A1 (en) Preparation method for morpholinquinazoline compound and midbody thereof
TW434206B (en) Methods for the preparation of pyridine derivatives for preparing an antisecretory compound, omeprazole
TW473476B (en) Process for the preparation of substituted 2-(2-pyrdiylmethyl) sulphinyl-1h-benzimidazoles
CA3122182A1 (en) Pharmaceutical process and intermediates
US7595417B2 (en) Cyanation of aromatic halides
US10099981B2 (en) Methods for meta-arylation of aromatic alcohols
TW200303751A (en) Preparation of N1-(2'-pyridyl)-1, 2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
CN105541796B (en) A kind of synthetic method of the triazole Bipyridine compounds of NH 1,2,3
CN111333543A (en) Synthesis method of rilpivirine intermediate
KR20050102077A (en) Novel process for the preparation of 2-aminomethylpyridine derivative
CN101638406A (en) Phthalide preparing method
CN105111191A (en) Key intermediate for synthesis of CDK9 inhibitor, preparation method and application thereof
Shoji et al. Synthesis of 2-Aryl-and 6-Heteroaryl-1, 3-di (4-pyridyl) azulenes by Katritzky’s Pyridylation of 2-Aryl-and 6-Heteroarylazulenes
BG65387B1 (en) Method for producing 4-(heteroaryl-methyl)-halogen-1(2h)-phthalazinones
WO1999000370A1 (en) 6-phenoxypicolinic acid, alkylidenehydrazide derivatives, process for producing the same, and herbicide
Sarrafi et al. Microwave-assisted chemoselective copper-catalyzed amination of o-chloro and o-bromobenzoic acids using aromatic amines under solvent free conditions

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MM4A Annulment or lapse of patent due to non-payment of fees